These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000039-27 A pivotal phase 3 study of MEDI-524 (Numax), an enhanced potency humanized respiratory syncytial virus (RSV) monoclonal antibody, for the prophylaxis of serious RSV disease in high-risk children. 2006-05-29 due-trials
Completed, but no date, and reported results 2004-000211-26 A comperative, placebo-controlled, doubleblind, double dummy, cross over, single center phase IIIb study between formoterol alone and the fixed combination of formoterol and budesonide on airway respo... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000344-24 A phase II, randomised, double-blind, parallel-group, placebo-controlled, multi-centre study to assess the efficacy and safety of once-daily orally administered ZD4054 15 mg and 10 mg doses in pain-fr... 2009-02-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000347-14 A 52-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Administered to... 2007-03-02 bad-data
Reported results 2004-000348-25 GALLANT 8 - A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Added to the Thera... 2006-03-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-000350-24 A 16-Week Randomized, Double-blind, Parallel-group, Multicentre, Placebo- and Active- Metformin Controlled Study to Evaluate the Effect on Whole Body Insulin Sensitivity of Tesaglitazar Therapy when... 2006-07-31 bad-data
Ongoing, reported early 2004-000352-16 A Double-blind, Double-dummy, Parallel Group Randomised Dose Confirmation and Feasibility Study of AZD6140 + Acetyl Salicylic Acid (ASA) Compared with Clopidogrel + ASA in Patients with Non-ST Segment... not-yet-due
Completed, but no date, and reported results 2004-000358-21 A Phase II Randomised, Double-blind, Placebo-controlled, Multicentre Comparative study of ZD1839 250 mg or 500 mg (Iressatm) given either continuously or concomitantly with cisplatin plus radiotherapy... bad-data
Completed, but no date, and reported results 2004-000359-41 A Controlled, Randomised, Parallel, Multicentre Study to Assess Safety and Tolerability of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and other Thromboembolic Complications... bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000379-32 A Randomized, Partially Blinded, Phase II Study to Assess the Safety, Tolerability, and Efficacy of ZD6474 Alone or in Combination with Paclitaxel and Carboplatin in Subjects with Previously Untreated... 2007-10-31 bad-data
Completed, but no date, and reported results 2004-000383-27 A double-blind randomized placebo controlled crossover study of AZD7371 ER 5 mg bid, 20 mg bid and placebo treatment for one week on visceral perception and symptoms in patients with Irritable Bowel S... bad-data
Ongoing, reported early 2004-000384-10 An Open-label, non-comparative, multi-centre study to assess the efficacy and safety of bicalutamide when used in combination with anastrozole for the treatment of gonadotropin-independent precocious ... not-yet-due
Ongoing 2004-000495-14 A PHASE II, MULTICENTRE, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND TOLERABILITY OF ZD1839 (IRESSA?) IN COMBINATION WITH CASODEX? IN PATIENTS WITH OPERABLE PROSTATE CANCER not-yet-due
Completed, but no date, and reported results 2004-000566-12 CHANT (Cerebral Hemorrhage And NXY Treatment) A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase IIb study to assess the safety and tolerability of 72 hours intravenous... bad-data
Ongoing, reported early 2004-000585-13 A Randomized, Double-Blind Trial to Assess the Safety and Relative Efficacy of CAIV-T Against Inactivated Influenza Vaccine in Children 6–59 Months of Age not-yet-due
Reported results 2004-000679-32 A comparison of the efficacy of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 microg, one inhalation twice a day plus as-needed) and conventional best standard treatment for the treat... 2006-12-19 due-trials
Reported results 2004-000727-15 A Randomized, Double Blind, Multicenter Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) vs. Exemestane (AROMASIN™) in Postmenopausal Women with Hormone Receptor Positive Adva... 2014-09-04 due-trials
Reported results 2004-000750-22 A 6-week, International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Phase IIIb Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Immediate-release Tabl... 2007-08-28 due-trials
Reported results 2004-000751-42 A 26-week, International, Multicenter, Open-label Phase IIIb Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in Chi... 2008-05-11 due-trials
Reported results 2004-000795-14 A Multicentre, Randomised, Double-blind, Placebo-controlled, Study on the Use of Prophylactic Meropenem Therapy in Subjects with Severe Acute Necrotizing Pancreatitis 2005-03-14 due-trials
Ongoing, reported early 2004-000912-13 A 6-WEEK INTERNATIONAL, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE FEASIBILITY OF SWITCHING FROM IMMEDIATE-REALESE QUETIAPINE FUMARATE SEROQUEL TM TO SUST... not-yet-due
Reported results 2004-000913-21 A 12-week International, Multicenter, Open Label, Non-comparative Study to Evaluate the Feasibility of Switching any Antipsychotic Treatment to Sustained-release Quetiapine Fumarate (SEROQUEL) in Pati... 2006-12-19 due-trials
Reported results 2004-000915-25 Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 weeks Maintenance T... 2007-06-05 due-trials
Completed, but no date, and reported results 2004-001107-36 A comparison of Symbicort Single inhaler Therapy (Symbicort Turbohaler 160/4.5 mg, 1 inhalation b.i.d. plus as needed) and conventional best practice for the treatment of persistent asthma in adolesce... bad-data
Ongoing, reported early 2004-001144-71 A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Added to the Therapy of Patien... not-yet-due
Reported results 2004-001168-28 A 12-month, double-blind, double-dummy, randomized, parallel group, multicenter efficacy and safety study of Symbicort® pMDI 2x160/4.5μg bid and 2x80/4.5 μg bid compared to Formoterol TBH 2x4.5μg bid ... 2007-11-30 due-trials
Reported results 2004-001183-41 A 6-month, double-blind, double-dummy, randomised, parallel group, multicenter, efficacy and safety study of Symbicort® pMDI 2x160/4.5μg and 2x80/4.5μg bid compared to Formoterol Turbuhaler, Budesoni... 2007-01-03 due-trials
Completed, but no date, and reported results 2004-001724-20 A randomised, placebo-controlled, double-blind, double-dummy, crossover study to assess the onset of action of two inhalations of Symbicort 160/4.5μg compared with two inhalations of Seretide 25/250μ... bad-data
Ongoing, reported early 2004-002370-39 A Phase III, Multicentre, Randomized, Double-blind Parallel-group Study to Evaluate the Safety and Clinical Outcome of Once Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease GER... not-yet-due
Ongoing 2004-002371-16 A Randomised, Double-Blind, Parallel-group, Multicentre, Phase III Study Comparing the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500 mg with Fulvestrant (FASLODEX™) 250 mg in Postmenopausal... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-002549-11 An Open-label, Multi-Centre and Long-Term Extension Study to Evaluate the Safety and Tolerability of oral Tesaglitazar 1 mg in patients with Type 2 Diabetes. 2007-02-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-002550-56 A 24-week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Active-Controlled (Metformin or Metformin Combined with Fenofibrate) Study to Evaluate the Lipid Metabolic Effects, Glycaemic Effects,... 2007-02-26 bad-data
Reported results 2004-002662-38 A PHASE III RANDOMISED, STRATIFIED, PARALLEL-GROUP, MULTI-CENTRE, COMPARATIVE STUDY OF ZD1839 (IRESSA®) 250 MG AND 500 MG VERSUS METHOTREXATE FOR PREVIOUSLY TREATED PATIENTS WITH SQUAMOUS CELL CARCINO... 2007-03-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-002746-35 The "EXTEND" study: A randomized, double-blind, parallel-group, phase IIIb, multi-centre study evaluating extended prophylactic treatment with melagatran/ximelagatran versus enoxaparin for the prevent... 2006-08-29 bad-data
Reported results 2004-002943-28 A randomised, open -label, parallel-group, international, multicenter phase III study of oral ZD1839 (IRESSA) versus intravenous docetaxel (Taxotere) in patients with locally advanced or metastatic re... 2007-07-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-003617-16 A Randomized, Open-label, Multicenter, Phase II Study Comparing the Effects on Proliferation and the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500 mg with Fulvestrant (FASLODEX™) 250 mg whe... 2007-07-09 bad-data
Ongoing 2004-003657-99 A double-blind, randomised, placebo controlled study to evaluate the safety and efficacy of A-60444 in adults with RSV infection following stem cell transplantation not-yet-due
Ongoing, reported early 2004-003826-92 "A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by day... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-003840-22 A Double-blind, Multi-centre, Active-Controlled (15, 30, and 45mg Pioglitazone) Long-Term Extension Study to Evaluate the Safety and Tolerability of Oral Tesaglitazar (0.5 and 1 mg) in Patients with T... 2007-02-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004042-41 A comparison of the inflammatory control of asthma provided by one inhalation of Symbicort® Turbuhaler® 160/4.5 µg/inhalation b.i.d. plus as-needed versus one inhalation of Symbicort® Turbuhaler® 320/... 2007-10-26 bad-data
Reported results 2004-004094-28 A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase III Study of Rosuvastatin (CRESTOR) 20 mg in the Primary Prevention of Cardiovascular Events Among Subjects with Low Levels of LDL Ch... 2008-10-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004206-25 A PHASE II MULTICENTRE RANDOMISED, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ZD1839 (IRESSA TM) (250MG TABLET) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IN CHEMOTHERAPY-N... 2007-02-22 bad-data
Not reported 2004-004229-93 Multicentre, open label, extension study of treatment with gefitinib (IRESSA™) for patients completing other gefitinib clinical studies who may benefit from gefitinib treatment 2017-10-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004264-75 A dose ranging, safety and pharmacokinetics study of Candesartan Cilexetil in hypertensive pediatric subjects 1 to less than 6 years of age a 4-week, multicenter, randomised, double blind study with ... 2008-09-16 bad-data
Reported results 2004-004374-90 A 24-Week Randomized, Double-Blind, Parallel-Group, Multi-Centre, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Tesaglitazar Therapy when Administered as Monotherapy to... 2007-02-09 due-trials
Reported results 2004-004681-33 An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600 mg... 2007-06-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-004803-39 SAINT II (Stroke - Acute Ischemic - NXY Treatment) A double blind, randomized, placebo controlled, parallel group, multicenter, phase IIb/III study to assess the efficacy and safety of intravenous NXY... 2006-10-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2004-004905-11 Efficacy and safety of Symbicort® Turbuhaler® 160/4.5 µg/inhalation, two inhalations twice daily plus as-needed compared with Seretide™ Diskus™ 50/500 µg/inhalation, one inhalation twice daily plus te... 2006-06-16 bad-data
Completed, but no date 2004-004907-39 A Phase II, double-blind, randomized, cross-over, international, multicentre study to evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 300 mg b.i.d. compared with placebo in p... bad-data
Ongoing 2004-004908-21 A Phase II, double-blind, randomized, cross-over, international, multicentre study to evaluate the analgesic efficacy of 3 weeks oral administration of AZD4282 300 mg b.i.d. compared with placebo in p... not-yet-due
Ongoing, reported early 2004-004909-16 An International, Multi-centre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel™, single oral 300 mg or 600 mg... not-yet-due
Ongoing 2004-005093-24 Multicentre, open label, extension study of treatment with gefitinib (IRESSA) for patients completing other gefitinib clinical studies who may benefit from gefitinib treatment not-yet-due
Reported results 2004-005122-45 RACE : Rapid Dose Escalation of Quetiapine versus Conventional Escalation in the Treatment of Patients with Acute Schizophrenia – a Multicentre, Double-blind, Parallel group, Randomized Study 2006-09-13 due-trials
Reported results 2004-005169-39 A single-blind single arm study to validate the Reflux Disease Questionnaire (RDQ) for the diagnosis of reflux disease in primary care in patients treated with esomeprazole 40 mg o.d. 2007-02-22 due-trials
Reported results 2004-005243-97 A Parallel-Group, Multi-Centre, Active-Controlled (Glibenclamide) Long Term Extension Study to Evaluate the Safety and Tolerability of oral Tesaglitazar Therapy in Patients with Type 2 Diabetes Mellit... 2007-02-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-000204-13 A double-blind, randomised, placebo-controlled, parallel-group, multicentre, phase II study to assess the efficacy of AZD7009 (AR-H065522XX) given intravenously (infusion for 15 or 30 minutes) to pati... 2006-05-09 bad-data
Not reported 2005-000211-99 Acutely Manic Patients Insufficiently Responding After 2 Weeks Continued Quetiapine Monotherapy: Continued Quetiapine Versus Sodium Valproate Add-on. 2006-10-05 due-trials
Reported results 2005-000258-64 SCORE An open, randomised, parallel, three treatment groups, multicentre, phase IV study - in real life - to compare the change in social outcome of quetiapine fumarate (Seroquel®) combined with Cogni... 2008-02-13 due-trials
Ongoing, reported early 2005-000372-41 Real life effectiveness in asthma of Symbicort® Single Inhaler Therapy (RELEASE) not-yet-due
Reported results 2005-000458-57 A randomised, open, phase IV, parallel group multicentre study to evaluate a change of management in Gastroesophageal Reflux Disease (GERD) patients by treatment with esomeprazole 40 mg or any other P... 2007-02-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-000532-25 A comparison of Symbicort Single inhaler Therapy (Symbicort Turbuhaler 160/4.5 mcg, 1 inhalation b.i.d. plus as needed) and conventional best practice for the treatment of persistent asthma in adolesc... 2007-03-30 bad-data
Reported results 2005-001090-10 A randomised, double blind, double dummy, multicentre phase III study comparing the efficacy of budesonide/formoterol (Symbicort® forte Turbuhaler®) and oral prednisolone + formoterol (Oxis® Turbuhale... 2007-09-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-001373-97 A Long-Term, Post treatment, Safety Follow-up, Multi-Centre Study in Patients with Type 2 Diabetes Mellitus from the GALLANT, GALLEX or ARMOR Studies, G-PLUS (GALLANT, GALLEX and ARMOR - Post treatmen... 2007-02-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001671-35 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children ... 2006-05-16 bad-data
Ongoing, reported early 2005-001737-15 An open-label, non-comparative, multi-centre, phase II prospective trial to assess the efficacy of Quetiapine fumarate augmentation of selective serotonin reuptake inhibitors (SSRIs) in SSRI-resistant... not-yet-due
Reported results 2005-002319-26 Efficacy and safety of AZD9056 200 mg once daily versus placebo in adult patients with active Crohn’s disease – A randomized, double-blind, four week, parallel-group, multicentre, phase II study 2007-05-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-002441-39 A randomised, double-blind, parallel-group, placebo controlled study of esomeprazole i.v. (bolus infusion of 80 mg followed by a continuous infusion of 8 mg per hour) administered for 72 hours to asse... 2008-01-04 bad-data
Reported results 2005-002508-41 A Randomised, Double-Blind, 52-week, Parallel-Group, Multicentre, Phase IIb Study to Evaluate the Effects of Rosuvastatin 10 mg, Rosuvastatin 40 mg and Atorvastatin 80 mg on Urinary Protein Excretion ... 2009-06-29 due-trials
Reported results 2005-002510-38 A Randomised, Double-Blind, 52-week, Parallel-Group, Multicentre, Phase IIb Study to Evaluate the Effects of Rosuvastatin 10 mg, Rosuvastatin 40 mg and Atorvastatin 80 mg on Urinary Protein Excretio... 2009-03-04 due-trials
Ongoing, reported early 2005-002584-90 A Randomised, Double-Blind, Placebo-Controlled, Two-Way Crossover Study in Healthy Volunteers to Investigate the Effect of Oral Dosing with AZD8309 on Airway Inflammation as Assessed in Induced Sputum... not-yet-due
Completed, but no date, and reported results 2005-002805-21 A randomized, double-blind, placebo controlled, three-way crossover study exploring the efficacy of AZD3778 compared with placebo and an oral antihistamine (loratadine) in a model of seasonal allergic... bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002868-28 A Randomised, Open-Label, Parallel-Group, Multi-centre, Phase II Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 500mg with Anastrozole (ARIMIDEX™) 1mg as First Line Hormonal... 2014-10-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002892-34 Comparison of the Effects Noted in The ApoB/ApoA-I ratio Using Rosuvastatin and atorvastatin in patients with acUte coronary Syndrome 2007-11-22 bad-data
Ongoing, reported early 2005-003251-13 Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-003440-66 A Randomised, Double-blind, Multicentre Phase II/III Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX), to the Efficacy of Bevacizumab i... 2015-08-19 bad-data
Ongoing, reported early 2005-003441-13 A Two-part, Open-label, Multi-centre, Phase II Study in Patients with Advanced Solid Tumours, Consisting of a Randomised 2-period Crossover Protocol to Determine the Effect of Food upon the Pharmacoki... not-yet-due
Listed as ongoing, but also has a completion date 2005-003442-33 A Phase II, Randomised, Factorial, Double-blind Study to Investigate the Management of AZD2171-induced Hypertension and Efficacy of AZD2171 at Doses of 30 mg and 45 mg in Patients with Advanced Solid ... 2011-04-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003443-31 A Phase II, Double-blind, Randomized Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination wi... 2009-10-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003591-38 A phase II, double-blind, placebo controlled, randomised study to assess the efficacy and safety of ZD6474 in combination with Arimidex vs. Arimidex alone in patients with hormone sensitive (ER+ve and... 2006-08-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003592-20 A phase II, double-blind, placebo controlled, randomised study to assess the efficacy and safety of ZD6474 in combination with docetaxel (Taxotere) vs docetaxel alone as 2nd line treatment for advance... 2007-07-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003593-16 A phase II, double-blind, placebo-controleed, randomised study to assess the efficacy and safety of docetaxel (Taxotere)/ prednisolone/ ZD6474 vs. docetaxel/ prednisolone/ placebo in patients with hor... 2008-01-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-003745-14 A Multi-centre, Double-blind, Randomised Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Monotherap... 2007-09-12 bad-data
Reported results 2005-004001-29 An open label randomised parallel group multicentre study to compare ZOLADEX 10.8 mg given every 12 weeks with ZOLADEX 3.6 mg given every 4 weeks in pre-menopausal women with oestrogen receptor positi... 2009-11-18 due-trials
Reported results 2005-004032-48 A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Effect of Tesaglitazar 1 mg once daily on the Pharmacokinetics of Metformin Following Addition of Tesaglitazar to Metfo... 2007-01-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004110-32 A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase II Study to Assess The Efficacy of AZD9056 (single oral 400 mg dose) when Administered for 4 Weeks in Patients with M... 2006-11-16 bad-data
Ongoing 2005-004247-54 A Randomised, Double-blind, Parallel-group, Multicentre, Phase II Study to Evaluate the Efficacy and Tolerability of Fulvestrant (FASLODEX™) 250 mg, Fulvestrant (FASLODEX™) 250 mg (plus 250 mg Loading... not-yet-due
Reported results 2005-004543-57 A 6-month randomized, double-blind, parallel-group, multicentre, placebo-controlled Phase II study to compare anti-asthmatic effect and safety of esomeprazole (Nexium) 40 mg twice daily or 40 mg once ... 2008-05-21 due-trials
Reported results 2005-004548-30 A Phase II randomised, double-blind, stratified, multi-centre trial comparing the Nolvadex 20 mg and placebo combination to the Nolvadex 20 mg and ZD1839 (IRESSA™) 250 mg combination in patients with ... 2015-06-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004749-32 A Phase III, Randomized, Double-Blinded, Multi-Center Study to Assess the Efficacy of Docetaxel TAXOTERE in Combination with ZD6474 ZACTIMA versus Docetaxel TAXOTERE in combination with Placebo ... 2012-11-09 bad-data
Ongoing 2005-004893-26 An open-label, non-comparative trial to evaluate the safety, efficacy and pharmacokinetics of FASLODEX (fulvestrant) in girls with progressive precocious puberty associated with McCune-Albright Syndro... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005052-40 A Multi-Centre, Double-Blind, Randomised, Parallel Group, Placebo-Controlled and Active Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) a... 2007-07-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005053-22 A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination with an ... 2007-05-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005054-46 An International, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-controlled Study of the Efficacy and Safety of Sustained-release Quetiapine Fumarate (Seroquel SR™ )... 2007-07-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005055-18 A Multi-centre, Double-blind, Randomised-Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR™) as Monotherap... 2007-10-11 bad-data
Listed as ongoing, but also has a completion date 2005-005077-29 An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMA ) versus Placebo in Subjects with Unresectable Locally Advance... 2015-11-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005715-22 A randomised Phase II Study comparing anastrozole and fulvestrant to an-astrozole for adjuvant treatment of postmenopausal patients with early breast cancer and disseminated tumour cells in bone marro... 2007-10-22 bad-data
Ongoing, reported early 2005-005717-38 An Open-Label, Phase II Study to Evaluate the Biological Activity of AZD2171, as Measured by FDG-PET Response, in Patients with Metastatic Gastro-Intestinal Stromal Tumours (GIST) Resistant or Intoler... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-005718-19 A Double Blind, Randomised, 3-arm Parallel Group, Multicentre, 8-week, Phase III Study to Assess the Antihypertensive Efficacy and Safety of the Combination of Candesartan Cilexetil/Hydrochlorothiazid... 2007-10-24 bad-data
Ongoing, reported early 2005-005974-64 Comparación del tratamiento con un único inhalador de Symbicort (Symbicort Turbuhaler 160/4,5 mg, 1 inhalación 2 veces/día como dosis de mantenimiento, y a demanda para el alivio de los síntomas, SM... not-yet-due
Ongoing, reported early 2006-000257-22 A study to assess the effectiveness of esomeprazole 40 mg once daily in subjects with continuing gastroesophageal reflux disease (GORD) symptoms following treatment with a previous full dose proton pu... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-000259-16 A Phase III, Randomised, Double-Blind, Multi-Centre Parallel-Group Study to Assess the Efficacy of ZD6474 (ZACTIMA™ ) Versus Erlotinib (TARCEVA®) in Patients With Locally Advanced or Metastatic (Stage... 2016-11-15 bad-data
Ongoing, reported early 2006-000320-14 Anastrozole monotherapy versus maximal oestrogen blockage with anastrozole and fulvestrant combination therapy: An open, randomised, comparative, phase III multicentre study in postmenopausal women wi... not-yet-due
Reported results 2006-000418-20 A 4-week randomized, double-blind, placebo controlled, parallel group, phase II study to assess the efficacy and safety of gefitinib tablets, 250 mg once daily (OD), in adult patients with moderate ch... 2006-12-15 due-trials
Not reported 2006-000574-69 Development of an algorithm for identification of responders to short term treatment with esomeprazol (Nexium) in primary care. 2007-03-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000658-27 A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coro... 2009-05-20 bad-data
Not reported 2006-000954-31 Centralised Pan-European Survey on the Undertreatment of Hyperchlesterolemia 2007-03-22 due-trials
Ongoing 2006-000978-68 Treatment of systemic effects in patients with COPD not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-001193-25 A 4 week randomised, double blind, placebo controlled, parallel group, phase II, PoP study to assess the efficacy and safety of AZD1981 in adult patients with asthma. 2007-08-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001194-14 A Randomised, Double-blind, Phase III Study to Compare the Efficacy and Safety of AZD2171 when added to 5 fluorouracil, Leucovorin and Oxaliplatin (FOLFOX) or Capecitabine and Oxaliplatin (XELOX) with... 2016-08-17 bad-data
Reported results 2006-001195-21 A Multicenter, Double-blind, Randomised, Parallel Group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR™) as Mono-therapy in the Tr... 2008-05-22 due-trials
Reported results 2006-001196-38 A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) as Mono-Therapy in the ... 2008-02-04 due-trials
Listed as ongoing, but also has a completion date 2006-001197-24 A Phase II, Double-blind, Randomised, Parallel Group, Multi-centre Study Comparing gefitinib 250 mg (IRESSA™) with erlotinib 150 mg (Tarceva®) in Previously Treated Patients with Locally Advanced or M... 2007-09-18 bad-data
Reported results 2006-001259-36 A randomised, parallel group, single blind, multicentre, 9-month, phase IV study in a primary care setting, comparing treatment guided by clinical symptoms and signs and NT-proBNP vs treatment guided ... 2009-01-16 due-trials
Reported results 2006-001316-76 A randomized, open, parallel-group, multi-centre, phase IV study to evaluate the efficacy of three different patient management strategies with and without esomeprazole 20 mg during a 3 months mainten... 2007-10-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001354-28 A Phase II, open-label study to assess the efficacy and tolerability of ZD6474 ZACTIMA 100 mg monotherapy in subjects with locally advanced or metastatic hereditary medullary thyroid cancer 2014-05-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001456-12 A Phase II, Multi-centre, Open-Label, Parallel Group, Randomised Study To Compare the Efficacy of AZD6244 vs Temozolomide in Patients with Unresectable AJCC Stage 3 or 4 Malignant Melanoma 2013-07-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001457-10 A Phase II, Open, Randomised Study to Assess the Efficacy and Safety of AZD6244 vs capecitabine (Xeloda) in Patients with Colorectal Cancer who have Failed One Or Two Prior Chemotherapeutic Regimens. 2007-07-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002001-31 A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of esomeprazole once daily for the treatment of gastroesophageal reflux disease (GERD) in neonatal patients, in... 2009-04-19 bad-data
Reported results 2006-002384-12 A Phase III, International, Randomised, Double-Blind, Parallel-Group, Multi-Centre Study to Assess the Efficacy of ZD6474(ZACTIMA™) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care i... 2014-11-30 due-trials
Reported results 2006-002412-10 A randomized, double-blind, double-dummy, two-way cross-over 2007-12-18 due-trials
Ongoing, reported early 2006-002455-33 A Phase II, Randomised, Double-blind, Parallel Group Study to Assess the Efficacy of AZD2171 45mg Versus Placebo following 12 Weeks of Treatment in Patients with Metastatic or Recurrent Renal Cell Car... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-002616-96 A phase IIIb, efficacy, and safety study of rosuvastatin in children and adolescents 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH): a 12-week, double-blind, randomized, ... 2008-06-04 bad-data
Ongoing, reported early 2006-002867-19 Evaluation de l’efficacité de 3 stratégies de prise en charge au long cours des symptômes de reflux gastro-oesophagien en médecine générale : étude multicentrique, randomisée, en ouvert, réalisée en g... not-yet-due
Completed, but no date, and reported results 2006-003286-14 A phase IV, 6-week, randomised, double-blind, multicentre, parallel group, comparative study to evaluate the efficacy of rosuvastatin 5 mg and atorvastatin 10 mg in UK Asian subjects with primary hype... bad-data
Ongoing, reported early 2006-003519-33 RAPID - An Open-Label, Randomised, Multicentre Phase IIIb Study to Evaluate the Efficacy and Tolerability of Quetiapine IR (Immedicate Release), over 14 days, in Acute Schizophrenia / Schizoaffective ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-003541-16 A randomized, double-blind, placebo controlled, multi-centre, phase IIA study to assess the effect on GERD symptoms, pharmacokinetics, safety and tolerability of four weeks treatment with AZD3355 65 m... 2007-07-10 bad-data
Listed as ongoing, but also has a completion date 2006-003695-35 A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 ZACTIMA in Combination with Pemetrexed Alimta versus Pemetrexed alone in ... 2009-10-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003963-30 A Double-blind, Randomised, 4-arm Parallel Group, Multicentre, 8-week, Phase III Study to Assess the Antihypertensive Efficacy and Safety of the Combination of Candesartan Cilexetil 32 mg and Hydrochl... 2008-02-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-004501-25 A double-blind, placebo controlled, randomized, two centre phase IIa pharmacodynamic cross-over study to assess the effect of AZD3355, 65 mg bid, on transient lower esophageal sphincter relaxations (T... 2008-05-12 bad-data
Ongoing 2006-004783-31 A Double-Blind, Randomised, Parallel-Group, Placebo-Controlled, MultiCentre, Phase IIa Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Multiple Oral Doses ... not-yet-due
Reported results 2006-005022-23 A Phase II, Double-Blind, Placebo Controlled, Randomised Study To Assess The Efficacy And Safety Of 2 Doses Of ZACTIMA (ZD6474) In Combination With FOLFOX vs FOLFOX Alone For The Treatment Of Colorect... 2016-11-11 due-trials
Ongoing, reported early 2006-005023-42 A phase II, double-blind, placebo controlled, randomised study to assess the efficacy and safety of 2 doses of ZACTIMA (ZD6474) in combination with FOLFIRI vs. FOLFIRI alone for the treatment of color... not-yet-due
Reported results 2006-005073-22 A randomized, double-blind, parallel-group, multicentre, phase III study to assess the effect of esomeprazole 20 and 40 mg od versus placebo on the occurrence of peptic ulcers during 26 weeks in subje... 2008-09-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-005212-27 A phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Treatment-withdrawal Study to Evaluate the Efficacy and Safety of Esomeprazole for the Treatment of Gastroesopha... 2008-07-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-005437-38 A Controlled, Randomized, Parallel, Multicentre Study to Assess Safety and Tolerability of the Oral Direct Thrombin Inhibitor AZD0837, given as an Extended-release Formulation, in the Prevention of St... 2008-07-08 bad-data
Completed, but no date, and reported results 2006-005677-22 A follow-up programme for patients using Symbicort® Turbuhaler® maintenance and reliever therapy in normal clinical practice bad-data
Reported results 2006-005746-36 A Phase II, Open, Randomised Study to Assess the Efficacy and Safety of AZD6244 vs. capecitabine (Xeloda) in Patients with Advanced or Metastatic Pancreatic Cancer, who have Failed First Line gemcitab... 2008-04-30 due-trials
Reported results 2006-006426-26 FAST – A randomised, open-label, parallel, multicentre Phase IIIb Study to evaluate the Efficacy and Safety of Quetiapine IR titrared over 4 Days in Patients with Acute Psychosis (Rapid versus Convent... 2008-04-23 due-trials
Reported results 2006-006427-39 The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorders with or without Psychotic Symptoms 2008-10-29 due-trials
Ongoing 2006-006458-91 A phase II, open-label, non-comparative, international, multicentre study to assess the efficacy and safety of KU 0059436 given orally twice daily in patients with advanced BRCA1- or BRCA2-associated ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006459-10 A phase II, open-label, non-comparative, international, multicentre study to assess the efficacy and safety of KU 0059436 given orally twice daily in patients with advanced BRCA1- or BRCA2-associated ... 2017-07-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006512-30 A Pan-European, open label, randomised study comparing the efficacy and cost-effectiveness of Symbicort Maintenance and Reliever Therapy (Symbicort SMART) using a maintenance dose of Symbicort 160/4.5... 2009-01-16 bad-data
Reported results 2006-006519-60 A multi-centre, randomised, double-blind, cross-over design study to evaluate efficacy on exercise tolerance of budesonide/formoterol (Symbicort®Turbuhaler®) 320/9 μg one inhalation twice daily compar... 2008-08-22 due-trials
Ongoing, reported early 2006-006697-15 Evaluation de l'efficacité et de la tolérance de rosuvastatine 5 mg versus pravastatine 40 mg et atorvastatine 10 mg chez des patients hypercholestérolémiques de type IIa et IIb not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006796-21 A 12-week, double-blind, randomised, parallel group, multi-centre, study to evaluate efficacy and safety of budesonide/formoterol (Symbicort® Turbuhaler®) 320/9 µg one inhalation twice daily on top of... 2008-07-15 bad-data
Ongoing, reported early 2006-006946-32 A Multi-centre Randomised, Double-blind, Double-dummy Parallel Group Study of the Onset and Offset of the Antiplatelet Effects of AZD6140 Compared with Clopidogrel and Placebo With Aspirin as Backgrou... not-yet-due
Completed, but no date 2007-000328-42 A clinical pharmacology study to determine the pharmacokinetic , safety and tolerability profile and antiviral activity of multiple oral doses of A-831 in otherwise healthy male Hepatitis C carriers ... bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000383-24 A Phase III, Randomised, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Patients to Compare the Efficacy of Cediranib [RECENTIN™, AZD2171] Monotherapy and the Combination of Cediranib wi... 2016-09-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000628-41 A Phase I, Randomized, Open-Label, Multi-National Study to Evaluate the Pharmacokinetics of Repeated Once-Daily Intravenous Doses of Esomeprazole in Paediatric Patients 0 to 17 Years Old, Inclusive 2009-11-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000835-24 A Multi-centre, Double-blind, Double-Dummy, Placebo-controlled, Parallel Group, Randomised, Phase IIb Proof of Concept Study with 3 oral dose groups of AZD3480 or donepezil during 12 weeks treatment i... 2008-08-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001337-34 A double-blind, randomised, cross-over, multi-centre study, to evaluate onset of effect in the morning in patients with severe Chronic Obstructive Pulmonary Disease (COPD) treated with budesonide/form... 2008-11-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001420-12 A Randomised, Double-Blind (with Open Comparator Etanercept Limb), Placebo-Controlled, Phase IIb, Multicentre Study to Evaluate the Efficacy of 4 Doses of AZD9056 Administered for 6 Months on the Sign... 2009-05-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-001545-17 An Open-Label Extension Study of Candesartan Cilexetil in Hypertensive Pediatric Subjects ages 1 to <11 years: A long Term Study. 2009-09-09 bad-data
Ongoing, reported early 2007-001722-27 Long-term treatment with the oral direct thrombin inhibitor AZD0837, compared to Vitamin-K antagonists, as stroke prevention in patients with non-valvular atrial fibrillation and one or more risk fact... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-001723-36 A controlled, randomized, parallel, multi-centre, feasibility study of the oral direct thrombin inhibitor AZD0837, given as extended-release formulation, in the prevention of stroke and systemic embol... 2008-11-27 bad-data
Listed as ongoing, but also has a completion date 2007-001890-27 A Randomised, double blind, placebo-controlled Phase II, Multi-Centre Study to Assess the Efficacy and Safety of Zactima™ in Patients with locally advanced or metastatic papillary or follicular Thyroi... 2008-09-22 bad-data
Ongoing, reported early 2007-001891-35 A randomized, double-blind phase II trial to assess the efficacy and safety of bicalutamide (Casodex® ) associated to ZD6474 (Zactima™ ) or to placebo in patients with castration-refractory metastatic... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-002070-61 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524, a Humanized Enhanced Potency Monoclonal Antibody Against Respiratory Syncytial Virus (RSV), in Children ... 2008-06-26 bad-data
Ongoing, reported early 2007-002090-31 A double-blind, placebo-controlled parallel-group study to assess the efficacy, safety, and tolerability of CAT-354 not-yet-due
Reported results 2007-002722-29 A 4-week, open-label, randomized, multi-centre, parallel-group study evaluating the safety and efficacy of 4 actuations Symbicort (budesonide/formoterol) HFA pMDI 40/2.25ug twice daily, with and witho... 2008-03-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002734-11 A 6-week, phase III, double-blind, randomized, multi-centre, parallel-group study evaluating the efficacy and safety of 2 actuations Symbicort® (budesonide/formoterol) pMDI 40/2.25 μg twice daily comp... 2008-04-17 bad-data
Reported results 2007-002810-20 A 12-week Open-Label, Randomised, Parallel-group, Multicentre, Phase IIIb Study to compare the Efficacy and Safety of rosuvastatin (CRESTOR) 10 mg and 20 mg in Combination with Ezetimibe 10 mg and Siv... 2008-12-12 due-trials
Ongoing, reported early 2007-003056-12 A RANDOMISED, MULTICENTRE, PHASE II, PARALLEL-GROUP TRIAL OF VANDETANIB MONOTHERAPY OR VANDETANIB IN COMBINATION WITH GEMCITABINE VERSUS GEMCITABINE PLUS VANDETANIB MATCHING PLACEBO IN SUBJECTS WITH A... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-003224-38 A Phase III, Randomised, Placebo-controlled, Double-blind Study to Assess the Efficacy and Safety of Once-daily Orally Administered ZD4054 10 mg in Non-metastatic Hormone-resistant Prostate Cancer Pat... 2011-02-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003227-20 A Phase III, Randomised, Double-blind Study to Assess the Efficacy and Safety of 10 mg ZD4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or... 2011-06-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003228-39 A Phase III, Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of 10 mg ZD4054 in Combination with Docetaxel in Comparison with Docetaxel in Patients with Metastat... 2011-06-30 bad-data
Reported results 2007-003455-36 A Multi-centre, Double-blind, Randomised, Placebo-controlled, Single-dose, Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness and Haemodynamics of an Intravenous Infusion of... 2008-07-09 due-trials
Reported results 2007-003633-16 A RANDOMIZED PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF VANDETANIB (ZD6474, ZACTIMATM) VERSUS VINORELBINE IN PATIENTS WITH INOPERABLE OR RELAPSED MALIGNANT MESOTHELIOMA 2009-08-26 due-trials
Reported results 2007-003962-16 A 4-week double-blind, placebo-controlled, randomised, parallel group phase IIa study to assess the tolerability/safety and efficacy of inhaled AZD4818 in patients with moderate to severe Chronic Obst... 2008-08-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-003998-55 A 52-Week International, Multi-centre, Randomised, Parallel-group, Double-blind, Active-controlled, Phase III study with a 52-Week Extension Period to Evaluate the Safety and Efficacy of Saxagliptin i... 2010-09-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-004000-13 A 104-week, randomized, double-blind, parallel group, multi-center Phase IIIb study comparing the effect of treatment with rosuvastatin 40mg or atorvastatin 80mg on atherosclerotic disease burden as m... 2011-08-10 bad-data
Completed, but no date, and reported results 2007-004246-32 Comparison of Quetiapine Extended-Release (Seroquel XR™ ) and Risperidone in the treatment of depressive symptoms, in schizophrenic or schizoaffective patients: A randomized, open label, flexible-dose... bad-data
Completed, but no date, and reported results 2007-004521-22 Phase II, Randomised, double-blind, two-arm, parallel study of Vandetanib (ZACTIMA , ZD6474) plus Gemcitabine (Gemzar ) or Gemcitabine plus Placebo as first line treatment of advanced (stage IIIB or I... bad-data
Ongoing 2007-004584-22 A Randomised, Double-Blind, Placebo-Controlled, Two-Way Crossover Study in Healthy Volunteers to Investigate the Effect of Oral Dosing with AZD9668 on Airway Inflammation as Assessed in Induced Sputum... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-004740-79 A One-Year Randomized, Prospective, Parallel, Open Comparison of Subjective Well-being in Schizophrenic Out-patients Treated with Quetiapine XR (SEROQUEL Prolong®) or Oral Risperidone at Flexible Dose... 2010-02-09 bad-data
Reported results 2007-004951-12 A Short-term 12-Week, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-controlled Study to Evaluate the Treatment Effect of Saxagliptin compared with Placebo in Adult Patients with Type... 2010-04-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005220-33 A 52-Week International, Multi-centre, Randomised, Parallel-group, Double-blind, Active-controlled, Phase III study with a 156-Week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozi... 2013-02-25 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005325-30 A Phase II, Double-Blind, Placebo Controlled, Multi-Centre, Randomised Study of AZD0530 in Patients with Advanced Ovarian Cancer Sensitive to Platinum-Based Chemotherapy 2012-02-21 bad-data
Completed, but no date, and reported results 2007-005773-63 A Pilot Study of Three-Weeks, Randomized, Prospective, Open Comparison in Schizophrenic In-patients Treated with Quetiapine Prolong or Oral Risperidone at Flexible Dose bad-data
Reported results 2007-005931-27 A 24-Week Randomised, Double-blind, Parallel-group, Multi-centre, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Dapagliflozin in Combination with Glimepiride (a Sulphonylur... 2010-06-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005999-13 A Phase II, Randomised, Open-label, Pilot Study to Evaluate the Safety and the Effects on Bone Resorption of AZD0530 in Patients with Prostate Cancer or Breast Cancer with Metastatic Bone Disease 2012-08-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-006095-11 An 18-week, International, Multi-centre, Randomized, Parallel-group, Double-Blind, Active-Controlled Phase IIIb Study to Evaluate the Efficacy and Safety of Saxagliptin in combination with Metformin... 2009-04-07 bad-data
Ongoing, reported early 2007-006249-42 A Phase 3, randomised, open-label, cross-over study to compare HFA vs CFC pMDI formulations of budesonide on methacholine hyper-reactivity in patients with stable, persistent, mild to moderate asthma not-yet-due
Ongoing 2007-006250-25 A Phase III, Randomised, Double-blind, Multi-centre, Parallel Group Study to Compare the Efficacy of Cediranib (AZD2171, RECENTIN™) (30 mg) When Added to Gemcitabine and Cisplatin versus the Efficacy ... not-yet-due
Ongoing, reported early 2007-006647-45 A Phase I/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 inhibitor AZD1480 Administered Orally to Patients with Primary Mye... not-yet-due
Reported results 2007-007058-79 A Randomised, Placebo-controlled, Double-blind, Parallel-group, Multicentre, Phase IIa Study to Explore the Relationship between QTcF Interval at First Dose (Loading Dose) and at Steady State after Tr... 2008-09-30 due-trials
Reported results 2007-007127-40 CARE II - Evaluation of treatment outcomes in schizophrenic patients taking part in the integrated care program - a single-country, multi-centre phase IV study 2008-09-30 due-trials
Reported results 2007-007539-14 A Randomised, Double-Blind, Placebo-Controlled, Phase IIb Dose-Ranging Study (with Open-label Etanercept Treatment Group) to Investigate Efficacy, Safety and Pharmacokinetics of AZD5672 Administered... 2009-05-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-007540-10 A 24-week international, randomized, parallel-group, double-blind, placebo-controlled Phase III study with a 24-week extension period to evaluate the efficacy and safety of dapagliflozin therapy when ... 2011-03-14 bad-data
Ongoing 2007-007622-22 A Phase II, Open-Label, Randomised, Comparative, International Multicentre Study to Assess the Safety and Efficacy of Three Different Doses of AZD2281 Given Orally Once or Twice Daily and Intravenous ... not-yet-due
Listed as ongoing, but also has a completion date 2007-007623-40 A Phase II, Double-blind, Placebo-Controlled, Randomised Study to Assess the Efficacy and Safety of ZD4054 in Combination with Pemetrexed (Alimta®) vs. Pemetrexed Alone in Patients with Non-small Cell... 2010-09-24 bad-data
Ongoing 2008-000062-24 Ensayo fase I/II, abierto, multicéntrico, de AZD2281 oral en combinación con Cisplatino, para valorar la seguridad y tolerabilidad en pacientes con tumores sólidos avanzados, y para valorar la eficaci... not-yet-due
Reported results 2008-000311-15 A Double-Blind, Placebo-Controlled, Randomised, Parallel Group Phase IIa Study to Evaluate the Histological Changes, Cellularity, Clinical Efficacy and Safety of AZD1981 in Patients with Moderate to S... 2009-07-20 due-trials
Reported results 2008-000340-13 A 4 week double-blind, placebo-controlled, randomized, parallel group phase IIa study to assess the efficacy and safety of AZD1981 in patients with moderate to severe Chronic Obstructive Pulmonary Dis... 2009-03-03 due-trials
Ongoing, reported early 2008-000579-12 A randomised, double-blind, parallel-group, multicentre, phase ii study to evaluate the safety and pharmacological activity of the combination of Vandetanib (100 or 300 mg/daily or placebo) with Fulve... not-yet-due
Reported results 2008-000724-12 A 2-week, randomised, double-blind, placebo-controlled, parallel group study to assess the tolerability and pharmacokinetics of orally administered AZD9668 in patients with COPD 2008-10-29 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000744-13 An Open-Label, Multicenter Extension Study to Evaluate the Safety of R935788 in Patients with Rheumatoid Arthritis Who Have Completed the Treatment Phase of a Rigel-Sponsored R935788 Study 2013-08-21 bad-data
Reported results 2008-000753-35 A Phase II, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients with Bronchiectasis 2009-04-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000907-27 A Phase II, Single Arm, Single Agent, Multicentre, Adaptive 2-Stage Study to Evaluate the Efficacy, Safety and Pharmacokinetics of AZD4877 Administered Weekly in Patients with Recurrent Advanced Uroth... 2010-02-09 bad-data
Reported results 2008-000908-91 A randomised, 6-week, multicentre, open-label, rater-blinded parallel group study comparing Quetiapine extended release monotherapy and augmentation with Lithium augmentation in patients with Treatmen... 2009-08-17 due-trials
Ongoing 2008-000989-23 A ROLLOVER PROTOCOL FOR PATIENTS WHO RECEIVED CP-675,206 IN OTHER PROTOCOLS not-yet-due
Reported results 2008-001254-41 A single-centre, single-blind, randomised, placebo-controlled phase IIa study to investigate the effect of AZD1305 given as an iv infusion on left ventricular performance in patients with left ventric... 2009-08-19 due-trials
Reported results 2008-001530-27 A Phase II, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients with Cystic Fibrosis 2009-08-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-001724-32 A phase II, double-blind, placebo-controlled, randomised, 6-way cross-over, single-dose study to investigate the local and systemic effects of 3 doses of inhaled AZD3199 (a β2-agonist) compared to for... 2009-02-04 bad-data
Reported results 2008-002151-25 A Double-Blind, Randomised, Placebo-Controlled, Parallel Group Multi-Centre Phase IIa Study to Assess the Effects on Biomarkers in Induced Sputum, Blood and Urine of AZD1236 Administered as Oral Table... 2009-08-20 due-trials
Reported results 2008-002230-30 A 6 Week Double-Blind, Placebo-controlled, Randomised, Parallel Group Phase IIa Study to Assess the Tolerability/Safety and Efficacy of AZD1236 as an Oral Tablet in Patients with Moderate to Severe CO... 2009-07-21 due-trials
Reported results 2008-002332-15 A randomised, double-blind, placebo-controlled study to evaluate the transthoracic Doppler echocardiography method as a non-invasive method for coronary function measurements; ability to detect short-... 2009-05-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-002606-18 A Phase I/II, Open Label, Multi-centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Tor Kinase Inhibitor AZD8055 Administered Orally to Patients with Adva... 2010-11-29 bad-data
Listed as ongoing, but also has a completion date 2008-002608-25 A Phase I/II randomised, double-blind, multi-centre study to assess the efficacy of AZD2281 when given in combination with paclitaxel in the 1st or 2nd line treatment of patients with metastatic Tripl... 2018-02-19 bad-data
Completed, but no date, and reported results 2008-002649-22 Efectividad de quetiapina de liberación prolongada vs sertralina como terapia co-adyuvante al tratamiento eutimizante previo en la depresión bipolar aguda: un estudio piloto bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002651-24 A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, a Live, Attenuated I... 2012-08-23 bad-data
Ongoing 2008-003439-18 Estudio en fase II aleatorizado, doble ciego y multicéntrico, para evaluar la eficacia de AZD2281 en el tratamiento de pacientes con cáncer de ovario seroso sensible al platino tras el tratamiento co... not-yet-due
Listed as ongoing, but also has a completion date 2008-003698-42 A controlled, randomised, double-blind, double-dummy, parallel-group, phase III, multicenter study to evaluate efficacy and safety of the oral direct thrombin inhibitor AZD0837 compared to warfarin fo... 2013-08-13 bad-data
Not reported 2008-004699-34 A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II study to Assess the efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients with Cystic Fibrosis. 2009-04-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004913-93 A 24-week, Multi-centre, International, Double-blind, Randomized, Parallel-group, Placebo-controlled, Phase III Study with a 78-week Extension Period to Evaluate the Effect of Dapagliflozin in Combina... 2011-12-22 bad-data
Listed as ongoing, but also has a completion date 2008-004916-12 A 24-Week, International, Multi-centre, Randomised, Parallel-group, Double-blind, Active-controlled, Phase III study to Evaluate the Efficacy and Safety of Dapagliflozin in Combination with Metformin ... 2009-05-08 bad-data
Reported results 2008-005305-19 A Randomised, Double-Blind, Outpatient, Crossover Study of the Anti-platelet Effects of AZD6140 Compared with Clopidogrel in Patients with Stable Coronary Artery Disease Previuosly Identified as Clopi... 2009-04-20 due-trials
Completed, reported early 2008-005557-38 Addition of vandetanib to standard therapy (pegliposomal doxorubicin) in patients with recurrent ovarian cancer. A multi-centre, non-randomized, open phase I/randomized phase II study 2010-11-29 not-yet-due
Reported results 2008-006068-12 A Phase II, Double-blind, Placebo-controlled, Multi-centre, Randomised Study of ZD4054 plus Carboplatin and Paclitaxel or Placebo plus Carboplatin and Paclitaxel in Patients with Advanced Ovarian Canc... 2011-07-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006323-31 A Phase II, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy of AZD6244 (Hyd-Sulfate) in Combination with Docetaxel, Compared with Docetaxel Alone, in 2nd Line Patients with... 2011-09-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-006344-19 A Phase II, Double-Blind, Randomised Study to Assess the Efficacy of AZD6244 (Hyd-Sulfate) in Combination with Dacarbazine Compared with Dacarbazine Alone in First Line Patients with BRAF Mutation Pos... 2012-10-02 bad-data
Ongoing 2008-006742-26 Evaluation Study of a New Management Strategy for Gastroesophageal Reflux Disease (GERD) not-yet-due
Reported results 2008-006869-86 A comparison of Symbicort® Maintenance and Reliever Therapy (Symbicort Turbuhaler® 160/4.5 mg, one inhalation bid plus as-needed) and Symbicort Turbuhaler 160/4.5 mg, one inhalation bid plus terbutali... 2011-02-23 due-trials
Reported results 2008-007190-20 An International, Multicenter, Double-blind, Randomized, Placebo-controlled, Phase IV Study of the Safety and Efficacy of Lithium versus Placebo as an add on to SEROQUEL XR™ (Quetiapine Fumarate) in A... 2010-11-17 due-trials
Reported results 2008-007420-26 A phase IIa, double-blind, randomized, 2-way cross-over study to evaluate the effect of a single dose of AZD1386 95 mg compared to placebo in a multimodal experimental pain model on esophageal sensiti... 2011-01-12 due-trials
Reported results 2008-007797-37 A Phase II Randomised, Double-blind, Parallel Group, 4-week treatment, Adaptive Dose Finding, Multi-centre study evaluating the Efficacy, Safety, Tolerability and Pharmacokinetics of up to three diffe... 2009-07-14 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-007844-33 A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study to Evaluate the Efficacy and Safety of CAT-354, a Fully Human Monoclonal Antibody Directed Against Interleukin... 2010-08-03 bad-data
Reported results 2009-009862-15 A double-Blind, Randomised, Placebo-Controlled, Multicentre, Dose-Escalating Study of AZD1305 Given Intravenoulsy for Cardioversion of Atrial Fibrillation 2009-11-20 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010114-30 A randomised, open-label, multi-centre, 2-stage, parallel group study to assess the efficacy, safety and tolerability of AZD1152 alone and in combination with low dose cytosine arabinoside (LDAC) in c... 2012-04-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010551-26 A Phase I/II Multi-centre Study of AZD8931 in Combination with Weekly Paclitaxel to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced Solid Tumours and in a Sele... 2015-02-05 bad-data
Reported results 2009-010864-40 A double-blind, double-dummy, placebo-controlled, randomised, multi-centre, 5-way cross-over, single-dose study to investigate the local and systemic effects of inhaled AZD9164 compared to tiotropium ... 2009-11-26 due-trials
Reported results 2009-011044-20 A Single-Centre, Double-blind, Double-dummy, Randomised, Placebo Controlled, Four Period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600mg and 150mg) on QT/QTc Interval, Comp... 2009-07-01 due-trials
Reported results 2009-011148-21 A 12-week, randomised, double-blind, placebo-controlled, parallel group, multinational, phase IIb dose range finding study to evaluate the efficacy and safety of AZD9668 administered orally at 3 dose ... 2010-08-05 due-trials
Reported results 2009-011265-82 A 4-week, phase-II, double-blind, placebo-controlled, randomized, parallel group, multi-centre study to assess the efficacy and tolerability/safety of inhaled AZD3199 once daily compared to 9 μg formo... 2010-03-19 due-trials
Listed as ongoing, but also has a completion date 2009-012094-35 A Phase IIa randomised, double-blind, placebo controlled, parallel group, multicentre study evaluating the efficacy, safety, tolerability and pharmacokinetics of AZD1386 after 3 weeks of treatment in... 2009-12-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012541-33 A randomised, placebo-controlled, double-blind (double-dummy technique), crossover, multi-centre study, to evaluate onset of effect in patients with Chronic Obstructive Pulmonary Disease (COPD) treate... 2010-05-19 bad-data
Reported results 2009-012612-41 A 4-month, Randomized, Double-blind, Placebo- and Active-Controlled, Multi-centre, Parallel-Group study to Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Typ... 2011-02-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012775-10 A 24-Week, Randomised, Double-Blind, Active-Controlled, Multi-Centre Phase IIIb/IV Study to Evaluate the Efficacy and Tolerability of Saxagliptin Add-on Compared to Uptitration of Metformin in Patient... 2010-12-03 bad-data
Reported results 2009-012805-20 A randomised, double blind, placebo controlled, parallel-group study with use of budesonide/formoterol “as-needed”, or terbutaline “as-needed” or regular use of budesonide + terbutaline “as-needed”, i... 2010-07-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-012806-37 A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, International Phase III Study with a 24-week Extension Period to Evaluate the Safety and Efficacy of Dapagliflozin... 2011-09-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012816-41 A 52-Week, Randomised, Double Blind, Active-Controlled, Multi-Centre Phase IIIb/IV Study to Evaluate the Efficacy and Tolerability of Saxagliptin Compared to Glimepiride in Elderly Patients with Typ... 2012-06-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012934-63 A Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of AZD8931 In Combination with Anastrozole, Compared to Anastrozole alone, in Post-menopa... 2013-01-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-012935-13 A randomized, double-blind, placebo controlled, multi-centre phase IIb dose finding study to assess the effect on GERD symptoms, safety and tolerability during four weeks treatment with AZD3355 in dos... 2010-07-08 bad-data
Completed, reported early 2009-013110-27 A phase I, multi-centre, double-blind, placebo-controlled parallel group study to assess the pharmacoMRI effects of AZD6765 in male and female patients fulfilling the criteria for Major Depressive Dis... 2011-03-17 not-yet-due
No trial status on register 2009-013326-17 A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Children bad-data
Ongoing, reported early 2009-013705-34 A double-blind, placebo controlled, randomised, parallel group, single centre, phase IIa study to investigate the efficacy, tolerability and safety of 8 doses of AZD8848 administered intranasally once... not-yet-due
Reported results 2009-014586-75 A 12-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multinational, Phase IIb Study to Evaluate the Efficacy and Safety of 60 mg AZD9668 Administered Orally Twice Daily to Subjects... 2010-08-18 due-trials
Reported results 2009-014594-40 A 12-week, Phase-II, Double-Blind, Placebo-Controlled, Randomised, Parallel-Group, Multi-Centre Study to Assess the Effect of 60 mg AZD9668 Administered Orally Twice Daily on Structural Changes in the... 2010-11-17 due-trials
Reported results 2009-014735-20 A Phase 2 Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Efficacy and Safety of CAM-3001 in Subjects with Rheumatoid Arthritis 2012-07-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-015168-32 A Multicentre, Randomised, Double Blind, Placebo controlled Phase IIb Study to compare the Efficacy and Safety of Two Dosing Regimens of Intravenous Infusions of CytoFab™ (AZD9773) in Adult Patients W... 2012-05-25 bad-data
Reported results 2009-015525-37 Safety, Tolerability and Pharmacokinetics of 3 Dose regimens of AZD1446 vs. Placebo as an Add-on Treatment to Donepezil: A Multi-centre, Double-blind, Randomised, Placebo controlled, Parallel group Ph... 2010-07-29 due-trials
Ongoing 2009-015970-36 A Phase II, Open-Label, Randomised, Comparative, Multicentre Study to Compare the Efficacy and Tolerability of Olaparib in Combination with Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin... not-yet-due
Ongoing 2009-016378-34 An Open Label, Phase 1/2 Study of MEDI-551, a Humanized Monoclonal Antibody Directed Against CD19, in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies not-yet-due
Completed, but no date 2009-016468-35 A randomised, double-blind, phase III efficacy and safety study of cediranib (RECENTIN™ ) when added to cisplatin plus a fluoropyrimidine, compared with cisplatin plus a fluoropyrimidine alone, in pat... bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016492-29 An Efficacy and 2-Year Safety Study of Open-label Rosuvastatin in Children and Adolescents (aged from 6 to less than 18 years) with Familial Hypercholesterolaemia 2013-02-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016791-71 A 24-week, multicentre, randomised, double-blind, age-stratified, placebo controlled phase III study with an 80-week extension period to evaluate the efficacy and safety of dapagliflozin 10 mg once da... 2012-12-06 bad-data
Reported results 2009-017061-28 A 24-week, multicentre, randomised, double-blind, age-stratified, placebo controlled phase III study with a 28-week extension period to evaluate the efficacy and safety of dapagliflozin 10 mg once dai... 2013-01-18 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-017242-30 A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on a Background of Acetyl Salicyl... 2014-12-02 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017358-10 SAVOR Evaluación de saxagliptina a partir de los resultados vasculares registrados en pacientes con diabetes mellitus Ensayo clínico fase IV, multicéntrico, aleatorizado, doble ciego, controlado con p... 2013-05-16 bad-data
Listed as ongoing, but also has a completion date 2009-018157-23 A Phase IIa, Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel Group 12-Month Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of AZD3241 in Patients with Mu... 2010-12-16 bad-data
Ongoing, reported early 2010-018273-38 A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Pharmacodynamic Effect of Single and Multiple Oral Doses of AZD1446/ Placebo and a Single Dose o... not-yet-due
Reported results 2010-018315-15 A Phase 2, double-blind, randomized, parallel-group, placebo-controlled, multicenter study, comparing budesonide pMDI 160 μg bid with placebo, a 6-week efficacy and safety study in children aged 6 to ... 2013-04-05 due-trials
Ongoing, reported early 2010-018316-32 A Phase 2, randomized, blinded, 5-period cross-over, placebo and activecontrolled, multicenter, dose-finding study of single doses of formoterol 2.25 μg, 4.5 μg, and 9 μg delivered via Symbicort pMDI ... not-yet-due
Ongoing 2010-018361-33 A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in Pati... not-yet-due
Completed, but no date, and reported results 2010-018608-98 A double-blind, randomized, placebo-controlled, two-centre, phase IIa pharmacodynamic cross-over study to assess the effect of AZD2516 on the total number of reflux episodes in healthy male volunteers bad-data
Listed as ongoing, but also has a completion date and reported results 2010-018614-70 An Open Label, Multicentre, Single Arm Study to Characterise the Efficacy, Safety and Tolerability of Gefitinib 250 mg (IRESSA™) as First line Treatment in Caucasian Patients, who have Epidermal Growt... 2016-06-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019203-31 A Multicenter, Double-blind, Randomized, Placebo-controlled, 4-Armed Parallel Group Study to Evaluate the Efficacy of Zolmitriptan 0.5-, 2.5- and 5-mg Nasal Spray in the Treatment of Acute Migraine He... 2013-10-31 bad-data
Reported results 2010-019428-30 A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIIb tudy to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Metformin and Sulfonylurea in Subjects with ... 2011-06-14 due-trials
Reported results 2010-019511-37 A 16-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Safety and Efficacy of Dapagliflozin 2.5 mg BID, 5 mg BID and 10 mg QD Versus Placebo in Patients w... 2011-08-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-019785-90 A Phase IIa, Double-blind, Randomised, Parallel-group, Multi-centre Study to Evaluate the Analgesic Efficacy of 28 Days Oral Administration of AZD2423 Compared to Placebo in Patients with Posttraumati... 2012-04-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-019925-33 A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of TC-5214 (S-mecamylamine) in Flexible Doses as an Adjunct to an Antidepressant in Pat... 2011-09-27 bad-data
Reported results 2010-020126-17 A Phase 2b, dose-ranging study to evaluate the efficacy and safety of MEDI-563 in adults with uncontrolled asthma 2013-08-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020127-52 A Phase 2a, double blind, placebo controlled study to evaluate the efficacy of MEDI-563 in subjects with moderate to severe COPD and sputum eosinophilia 2013-07-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020140-36 A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo- Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant... 2012-01-30 bad-data
Reported results 2010-020141-26 A Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase IIa Study to Investigate the Effects of 100mg AZD2423 as an oral tablet in Subjects with Mild COPD Following Segmen... 2011-07-28 due-trials
Reported results 2010-020407-73 A double-blind, placebo-controlled, randomised, parallel-group, phase-II, multi-centre study to assess the efficacy, safety and tolerability of 4 twice daily doses and 2 once daily doses of AZD1981 gi... 2012-02-16 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020579-21 A Phase IV Prospective, Double-blind, Double-dummy, Randomised, Crossover Study to Assess the Impact on Daily Cognitive Functioning of Quetiapine Fumarate Immediate Release (Seroquel IR) Dosed twice D... 2011-08-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020743-12 A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an Inadequate Respon... 2012-11-26 bad-data
Reported results 2010-020744-35 A Phase III, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with an Inadequate Respo... 2013-03-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020745-27 A Phase III, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Two Dosing Regimens of Fostamatinib Disodium in Rheumatoid Arthritis Patients with Inadequate Response ... 2013-02-11 bad-data
Reported results 2010-020747-13 A double-blind, placebo controlled, randomised, parallel group phase IIa study to investigate the efficacy, tolerability, and safety of different dosing regimens of AZD8848 administered intranasally t... 2012-02-10 due-trials
Completed, but no date, and reported results 2010-020820-23 A Phase 1/2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia bad-data
Reported results 2010-020891-43 A 4-week, Double-Blind, Placebo-Controlled, Randomised, Parallel group, Multi-Centre, Phase IIa Study to Investigate the Tolerability and Safety of 100 mg Oral AZD2423 in Patients with Moderate to Sev... 2011-03-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020892-22 A Long-term Extension Study to Assess the Safety and Efficacy of Fostamatinib Disodium (FosD) in the Treatment of Rheumatoid Arthritis 2013-06-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020932-20 A Double Masked, Placebo Controlled, Randomised, Parallel Group Phase 2012-11-30 bad-data
Reported results 2010-021217-23 A 4 Week, Double Blind, Placebo Controlled, Randomised, Parallel Group, Multicentre, Phase IIa Study to Investigate the Safety and Tolerability of AZD5069 as Oral Capsules in Patients with Moderate to... 2011-03-22 due-trials
Reported results 2010-021220-10 A Randomised Double-blind Phase IIa Study (with Combination Safety Run-in) to Assess the Safety and Efficacy of AZD4547 in Combination with Exemestane vs. Exemestane Alone in ER + Breast Cancer Patien... 2014-10-21 due-trials
Reported results 2010-021472-28 A Phase II Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the efficacy of 28-Day Oral Administration of AZD5069 Twice Daily in Patients with Bronchiectasis. 2012-02-10 due-trials
Completed, reported early 2010-021520-10 An open, single centre, phase I study in male adolescents with asthma, aged 12 to 17 years, to assess pharmacokinetics of orally administered AZD1981 tablets 100mg twice daily for 6½ days 2011-02-02 not-yet-due
Ongoing 2010-022278-15 A Phase II, Open Label, Non Randomised, Non Comparative, Multicentre Study to Assess the Efficacy And Safety of Olaparib Given Orally Twice Daily in Patients With Advanced Cancers Who Have A Confirmed... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-023377-19 A Randomised Open-Label Phase IIa Study to Assess the Efficacy and Safety of AZD4547 monotherapy versus paclitaxel in Patients with Advanced Gastric or Gastro-oesophageal Junction Cancer with FGFR2 Po... 2015-02-11 bad-data
Listed as ongoing, but also has a completion date 2010-023428-26 A Randomized, International, Open-Label, Multi-Centre, Phase III Study to Assess the Effect of a Patient Outreach Program on the Percentage of Time Patients with Locally Advanced or Metastatic Medulla... 2013-04-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-023692-26 (OSKIRA-4): A Phase IIB, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Fostamatinib Disodium Monotherapy Compared with Adalimumab Mono... 2013-07-17 bad-data
Reported results 2010-023816-15 A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Active 2012-03-20 due-trials
Reported results 2010-023854-35 A Phase 1b/2 Randomized Study of MEDI-575 in Combination With Carboplatin Plus Paclitaxel Versus Carboplatin Plus Paclitaxel Alone in Adult Subjects With Previously Untreated, Advanced Non-Small Cell ... 2013-09-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-024069-30 A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults with Systemic Lupus Erythematosus 2014-08-20 bad-data
Completed, but no date, and reported results 2010-024137-22 A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Phase III, Efficacy and Safety Study of 3 Fixed Dose Groups of TC-5214 (S-mecamylamine) as an Adjunct to an Antidepressant ... bad-data
Reported results 2011-000133-37 A Randomized, Double-blind, Double-dummy, Placebo-controlled, 2012-02-27 due-trials
Ongoing 2011-000198-29 A Phase 1b/2 Randomized Study of MEDI-573 in Combination with an Aromatase Inhibitor (AI) Versus AI Alone in Women with Metastatic Breast Cancer (MBC) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-000214-19 A 30 day international, randomized, parallel-group, double-blind, placebo-controlled phase IV study to evaluate efficacy and safety of pre-hospital vs. in-hospital initiation of ticagrelor therapy in ... 2013-11-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001360-21 A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults with Uncontrolled, Severe Asthma 2014-02-22 bad-data
Reported results 2011-001716-59 A Multi-Centre, Double-Blind, Randomised, Placebo-Controlled Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness of an Intravenous Infusion of AZD2927 in Patients Undergoing ... 2011-12-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-001985-16 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Relieving Opioid-Induced Constipation (OIC) in Patients with Cancer-Related Pain. 2012-09-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001986-41 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC) 2012-09-21 bad-data
Reported results 2011-001987-24 A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NKTR-118 in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC) 2012-08-16 due-trials
Reported results 2011-002187-24 A Randomized, Double-Blind, Placebo-Controlled 12-Week Extension Study to Assess the Safety and Tolerability of NKTR-118 in Patients with Non-Cancer-Related Pain and Opioid-Induced Constipation (OIC) 2012-09-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002231-26 A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, International Phase III Study with a 28-week Extension Period to Evaluate the Safety and Efficacy of Dapagliflozin 10mg once daily... 2013-08-12 bad-data
Reported results 2011-002523-17 A 12-week, Double-blind, Randomized, Multi-centre, Parallel-group Study Evaluating the Efficacy, Safety, and Patient Use (User Study) of Symbicort® (Budesonide/Formoterol) Breath Actuated Metered Dose... 2012-08-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002563-23 A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease 2014-02-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-002565-38 A Phase 2 Randomized Open-label Study of MEDI-551 in Adults With Relapsed or Refractory DLBCL 2016-06-17 bad-data
Reported results 2011-002566-21 A Phase 2 Open-label Study of MEDI-551 and Bendamustine vs Rituximab and Bendamustine in Adults With Relapsed or Refractory CLL 2016-01-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002790-28 A 26 week, randomized, double-blind, parallel-group, active controlled, multicenter, multinational safety study evaluating the risk of serious asthma-related events during treatment with Symbicort®, a... 2015-10-13 bad-data
Reported results 2011-003742-40 A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort™ EC as a Maintenance Treatment for Crohn’s Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive 2014-02-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-003743-22 A Multicenter, Open label, Non-Comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive 2014-09-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003893-97 A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ104) Plus Metronida... 2014-04-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003895-35 A Phase III, Randomized, Multicenter, Double Blind, Double-Dummy Parallel-Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ104) Plus Metronida... 2014-04-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-004013-16 A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600mg every 8 hours) Versus Vancomycin Plus Aztreonam in the Treatment... 2015-01-02 bad-data
Reported results 2011-004296-36 A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects with Systemic Lupus Erythematosus 2015-04-08 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004616-36 A randomized, double-blind, parallel group, multicentre phase IIIb study to compare ticagrelor with clopidogrel treatment on the risk of cardiovascular death, myocardial infarction and ischemic stroke... 2016-09-26 bad-data
Reported results 2011-004641-41 A randomised, double-blind, placebo-controlled, multi-centre, 6-way cross-over, single-dose Phase IIa study to investigate the local and systemic effects of 3 different doses of inhaled AZD2115 compar... 2012-10-23 due-trials
Reported results 2011-004690-87 A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients with Major Depressive Disorder (MDD) and a History of... 2013-08-23 due-trials
Ongoing 2011-004701-24 An International, Randomised, Double-Blind, Two-Arm Study To Evaluate The Safety And Efficacy Of Vandetanib 150 And 300mg/Day In Patients With Unresectable Locally Advanced Or Metastatic Medullary Thy... not-yet-due
Reported results 2011-004803-19 A Phase IIA, Multi centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Effect of 8 Weeks Treatment with Oral AZD3241 on Microglia Activation, as Measured by Positr... 2013-01-09 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-004812-40 A phase IIa, randomised, double-blind, placebo-controlled, parallel-arm, multicenter study to evaluate the efficacy and safety of tralokinumab (CAT-354), a recombinant human monoclonal antibody direct... 2013-06-24 bad-data
Ongoing 2011-004942-16 A Phase III Randomised, Double blind, Placebo controlled, Parallel, Multicentre Study to Assess the Efficacy and Safety of continuing IRESSATM 250 mg in addition to Chemotherapy versus Chemotherapy al... not-yet-due
Reported results 2011-005157-31 A phase II Open Label, Multicentre, Single Arm Study to Characterise the Efficacy, Safety and Tolerability of Gefitinib 250 mg (IRESSA™) as treatment re-challenge in Patients, who have Epidermal Gro... 2015-07-31 due-trials
Reported results 2011-005194-23 A Phase IIa Multi-centre Randomised Double-Blind Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of AZD8931 in Combination with Paclitaxel versus Paclitaxel alone in Patie... 2012-11-08 due-trials
Reported results 2011-005389-39 A phase-II, double-blind, placebo-controlled, randomised, parallel-group,multi-centre study to assess the efficacy and safety of two staggered dose levels of inhaled once daily AZD5423 or twice daily ... 2013-06-07 due-trials
Ongoing, reported early 2011-005475-16 A Phase 1/2 Randomized, Dose-finding Study of MEDI-551 in Subjects with Relapsing-Remitting Multiple Sclerosis not-yet-due
Reported results 2011-005503-33 A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of Tralokinumab in Adolescents with Asthma 2013-01-09 due-trials
Reported results 2011-005634-19 A Phase 2b Study to Evaluate the Efficacy and Safety of Mavrilimumab in Subjects with Moderate-to-Severe Rheumatoid Arthritis. 2014-01-23 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-005648-93 An Open-label Extension Study to Evaluate the Long-term Safety of Mavrilimumab in Adult Subjects with Rheumatoid Arthritis 2016-12-30 bad-data
Reported results 2011-005649-10 A Phase 2 Exploratory Study of Mavrilimumab versus Anti tumor Necrosis Factor in Subjects with Rheumatoid Arthritis 2015-02-26 due-trials
Reported results 2011-005721-43 A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime-Avibactam (CAZ-AVI, formerly CAZ1... 2014-08-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-005722-21 A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime-Avibactam (CAZ-AVI, formerly CAZ1... 2014-09-22 bad-data
Reported results 2011-006070-73 A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients with Rheumatoid Art... 2013-01-15 due-trials
Ongoing 2011-006312-31 A Phase I/II, Multicentre, Study Comprising a Safety Run-In of AZD5363 when Combined with Paclitaxel in Patients with Advanced or Metastatic Breast Cancer; Followed by a Randomised Expansion of AZD536... not-yet-due
Reported results 2011-006323-37 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Triple Therapy with Saxagliptin added to Dapagliflozin in Combination ... 2015-01-12 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-006324-20 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Therapy with Dapagliflozin added to Saxagliptin in Combination with Me... 2015-02-19 bad-data
Ongoing 2011-006326-24 A Randomised, Double-blind, Parallel-group, Multicentre, Phase III Study to Compare the Efficacy and Tolerability of Fulvestrant (FASLODEX) 500 mg with Anastrozole (ARIMIDEX) 1 mg as Hormonal Treatmen... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-000726-21 An Open-Label, Randomized, Multicenter, Phase III Study of Ceftazidime Avibactam (CAZ-AVI) and Best Available Therapy for the Treatment of Infections Due to Ceftazidime Resistant Gram Negative Pathoge... 2014-10-29 bad-data
No trial status on register 2012-000825-33 A Phase 3 Study of MEDI-524 (Motavizumab) for the Prevention of RSV Disease Among Native American Infants in the Southwestern United States bad-data
No trial status on register 2012-001136-61 A Phase III, Multicenter, Randomized, Double-blind, Parallel-group Study to Evaluate the Safety of Once Daily Esomeprazole for the Treatment of Clinically Diagnosed Gastroesophageal Reflux Disease (GE... bad-data
No trial status on register 2012-001155-39 Phase I trial of AZD2171, an orally bioavailable antiangiogenic agent, in children and adolescents with refactory or recurrent solid tumours or acute myelogenous leukemia bad-data
No trial status on register 2012-001156-19 A Randomized, Open-Label Study to Evaluate the Pharmacokinetics of Single Oral Doses of Esomeprazole Magnesium in Pediatric Patients 1 to 11 Years-Old Inclusive with Endoscopically-Proven Gastroesopha... bad-data
No trial status on register 2012-001157-97 A Randomized, Open-Label Study to Evaluate the Pharmacokinetics of Multiple Doses of Esomeprazole Magnesium in a Pediatric Population of 1 to 11 Year olds with Gastroesophageal Reflux Disease (GERD) o... bad-data
No trial status on register 2012-001158-25 A Randomized, Open-Label Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Esomeprazole Magnesium 20 mg and 40 mg in a Pediatric Population of 12 to 17 Year-Olds with Gastroesopha... bad-data
No trial status on register 2012-001159-37 A Single-Blind, Randomised, Parallel-Group, Single-Centre Pharmacokinetic and pH-Monitoring Study of Esomeprazole in Infants up to 24 Months of Age bad-data
No trial status on register 2012-001160-29 An Open Single-centre Study on the Pharmacokinetics and Pharmacodynamics of Esomeprazole After Once Daily Oral Administration for 7 Days in Preterm Infants and Neonates bad-data
No trial status on register 2012-001180-77 An open-label, non-comparative, multi-centre study to assess the efficacy and safety of bicalutamide when used in combination with anastrozole for the treatment of gonadotropin-independent precocious ... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-001869-33 A 6-month, Randomised, Double-blind, Placebo-controlled, Multi-centre, Parallel-group, Phase II Study with an Optional Safety Extension Treatment Period up to 6 months, to Evaluate the Efficacy, Safet... 2014-06-23 bad-data
Ongoing 2012-002206-52 A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects with Advanced Solid Tumors not-yet-due
Other 2012-002896-32 A multicenter, double-blind, placebo-controlled, pharmacokinetic, pharmacodynamic, safety and tolerability study in patients aged 12 to <18 years of age with a central venous catheter to support predi... not-yet-due
Completed, but no date, and reported results 2012-002900-42 A randomised, double-blind placebo- and active-controlled, multi-centre, 6-way cross-over, single-dose phase IIa study to investigate the bronchodilatory and systemic effects of 4 different doses of i... bad-data
Listed as ongoing, but also has a completion date and reported results 2012-003101-10 A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects with Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Or... 2015-11-03 bad-data
Listed as ongoing, but also has a completion date 2012-003524-21 A Phase 2b, Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Second- or Third-line Treatment of Subjects with Unresectable Pleural or Peritoneal Malignant Mesothelioma 2016-06-07 bad-data
Ongoing 2012-003622-25 A Phase II, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination with Docetaxel, Compared with Placeb... not-yet-due
Reported results 2012-003895-38 A randomised, double-blind, multinational study to prevent major vascular events with Ticagrelor compared to Aspirin(ASA) in patients with acute ischaemic stroke or Transient Ischemic Attack (TIA). [S... 2016-03-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004006-96 A Phase III, Randomized, Multicentre, Double-blind, Double-dummy, Parallel-group Comparative Study to Determine the Efficacy, Safety And Tolerability of Ceftazidime-Avibactam Versus Meropenem in the T... 2016-01-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004098-26 A Phase 2a Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects with Moderate to Severe Crohn’s Disease Who Have Failed or Are Intolerant to Anti-tumor Necrosis Factor-alpha Therapy 2016-12-14 bad-data
Listed as ongoing, but also has a completion date 2012-004619-30 A Phase 2, Open-label Extension Study to Evaluate Long-term Safety of MEDI-546 in Adults with Systemic Lupus Erythematosus 2018-07-19 bad-data
Ongoing 2012-004628-39 A Phase I/II, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Ascending Doses of AZD9291 in Patients with Advanced Non Small Cell Lung Ca... not-yet-due
Listed as ongoing, but also has a completion date 2013-000239-28 DECLARE 2018-09-11 bad-data
Ongoing 2013-000422-58 A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Phase III Study to Assess the Efficacy and Safety of Vandetanib (CAPRELSA™) 300 mg in Patients with Differentiated Thyroid Cancer That Is E... not-yet-due
Ongoing 2013-000423-14 A Randomised, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differe... not-yet-due
Reported results 2013-000788-98 A Randomised, Double-blind, Placebo-controlled Phase IIa Study to Assess the Pharmacodynamics, Safety, and Pharmacokinetics of AZD4901 When Given in Multiple Doses to Females with Polycystic Ovary Syn... 2014-07-25 due-trials
Ongoing 2013-001211-75 A Phase III Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed BRCA Mutated Ovarian Cancer Patients who are in Complete ... not-yet-due
Ongoing 2013-001551-13 A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following Fir... not-yet-due
Ongoing 2013-001676-38 A Phase III, Double-Blind, Randomised, Placebo-Controlled Study to Assess the Efficacy and Safety of Selumetinib (AZD6244; ARRY-142886) (Hyd-Sulfate) in Combination with Docetaxel, in Patients receivi... not-yet-due
No trial status on register 2013-001900-13 A Phase I Study to Assess the Pharmacokinetics, Safety and Tolerability of a Single Dose of Ceftazidime-Avibactam (CAZ-AVI) in Children From 3 Months of Age to <18 Years Who Are Receiving Systemic Ant... bad-data
Reported results 2013-002163-26 A multicentre, randomised, double-blind, parallel group, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of benralizumab in asthmatic adults and adolescents inadequatley controll... 2016-03-11 due-trials
Reported results 2013-002345-11 A multicentre, randomised, double-blind, parallel group, placebo-controlled, Phase III efficacy and safety study of benralizumab (MEDI-563) added to high-dose inhaled corticosteroid plus long-acting b... 2016-05-08 due-trials
Reported results 2013-002352-32 A multicentre, randomised, double-blind, paralllel group, placebo-controlled, Phase 3 efficacy and safety study of benralizumab (MEDI-563) added to medium dose inhaled corticosteroid plus long acting ... 2014-07-25 due-trials
Reported results 2013-002523-42 A multicenter, randomized, double-blind, parallel group, placebo-controlled, Phase 3 efficacy and safety study of benralizumab (MEDI-563) to reduce oral corticosteroid use in patients with uncontrolle... 2016-07-06 due-trials
Reported results 2013-003269-33 A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects with Inadequately Controlled, Severe Asthma 2017-03-01 due-trials
Ongoing 2013-003519-23 A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor 90 mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in ... not-yet-due
Ongoing 2013-003520-37 A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Study to Compare the Efficacy, Safety and Tolerability of Olaparib Versus Placebo When Given in Addition to Abiraterone Treatment i... not-yet-due
Reported results 2013-003545-41 A Randomised, Double-Blind Study to Assess the Efficacy of Selumetinib (AZD6244, Hyd-Sulfate) in Combination with Dacarbazine Compared with Placebo in Combination with Dacarbazine as First Systemic Th... 2016-10-26 due-trials
Ongoing 2013-003839-30 A randomised, double-blind, parallel group, placebo-controlled multi-centre Phase III study to assess the efficacy and safety of olaparib versus placebo as adjuvant treatment in patients with germline... not-yet-due
Other 2013-003935-32 A Phase I, Open-Label, Multicentre Study to Assess the Pharmacokinetics and Safety of Naloxegol in Paediatric Patients Ages ≥ 6 Months to < 18 Years Receiving Treatment with Opioids not-yet-due
Not reported 2013-004319-33 A Phase 2b, Randomized, Double blind, Placebo-controlled, Parallel group, Multicentre Dose finding Study to evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-... 2014-11-20 due-trials
Completed, reported early 2013-004473-28 A 52-week, double-blind, randomised, multi-centre, phase III, parallel-group study in patients 12 years and older with asthma, evaluating the efficacy and safety of Symbicort (budesonide/formoterol) T... 2018-02-12 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2013-004474-96 A 52-week, double-blind, randomised, multi-centre, parallel-group,Phase III study in patients 12 years and older with asthma, evaluating the efficacy and safety of Symbicort® (budesonide/formoterol) T... 2017-08-02 bad-data
Completed, report not yet due 2013-004579-11 A randomised, double-blind, double dummy, 56 week placebo-controlled, multicentre, parallel group, phase 3 study evaluating efficacy and safety of 3 benralizumab doses in patients with moderate to ver... 2018-04-09 not-yet-due
Listed as ongoing, but also has a completion date 2013-004590-27 Randomised, double-blind, 56 week placebo-controlled, parallel group, multicentre, phase 3 study to evaluate the efficacy and safety of 2 doses of benralizumab in patients with moderate to very severe... 2018-04-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-004674-97 A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects with Type 1 ... 2017-08-25 bad-data
Ongoing 2013-005137-20 A Phase III, Open Label, Randomised, Controlled, Multi-centre Study to assess the efficacy and safety of Olaparib Monotherapy versus Physician’s Choice Chemotherapy in the Treatment of Metastatic Brea... not-yet-due
Reported results 2013-005293-22 A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, 2016-04-15 due-trials
Ongoing 2013-005427-16 A Phase II, Non-comparative, Open label, Multi-centre, International Study of MEDI4736, in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB-IV) who have received at ... not-yet-due
Reported results 2013-005614-35 A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequate... 2017-07-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-005615-27 A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequate... 2017-09-21 bad-data
Ongoing 2014-000253-36 A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders... not-yet-due
Ongoing 2014-000336-42 A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cance... not-yet-due
Ongoing 2014-000338-46 A Phase III, Open-label, Randomised, Multi-centre, International Study of MEDI4736, Given as Monotherapy or in Combination with Tremelimumab, Determined by PD-L1 Expression, Versus Standard of Care in... not-yet-due
Ongoing 2014-000531-17 A Phase II, Open Label, Single-arm Study to Assess the Safety and Efficacy of AZD9291 in Patients with EGFRm+/T790M+, Locally Advanced or Metastatic NSCLC who have Progressed Following Prior Therapy w... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-000593-19 A Phase IIIB, 6-Month, Double-blind, Double-dummy, Randomized, Parallel-group, Multicenter Exacerbation Study of Symbicort® pMDI 160/4.5 µg x 2 Actuations Twice-daily Compared to Formoterol Turbuhaler... 2016-02-08 bad-data
Ongoing 2014-000594-39 A Phase III, Open Label, Randomized Study of AZD9291 versus Platinum-Based Doublet Chemotherapy for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has Progressed... not-yet-due
Ongoing 2014-000770-19 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating not-yet-due
Ongoing 2014-000780-40 A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients not-yet-due
Reported results 2014-000972-24 A Randomized, Double blind, Placebo controlled, Multi center, Cross over Study of Rosuvastatin in Children and Adolescents (aged 6 to <18 years) with Homozygous Familial Hypercholesterolemia (HoFH) 2015-07-02 due-trials
Ongoing, reported early 2014-001006-18 Multicenter, open-label, randomised, pharmacokinetic (PK) and pharmacodynamic (PD) dose-ranging Phase II study of ticagrelor followed by a double-blind, randomised, parallel-group, placebo-controlled ... not-yet-due
Completed, but no date, and reported results 2014-001053-16 A 12-week Phase IIa, Double-blind, Placebo-controlled, Randomized Study to Investigate the Efficacy and Safety of AZD7624 in COPD Patients with a History of Frequent Acute Exacerbations while on Maint... bad-data
Ongoing 2014-001069-28 A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction with EpaNova in HiGh Cardiovascular Risk PatienTs with Hypertriglyceridemia (STRENGTH) not-yet-due
Listed as ongoing, but also has a completion date 2014-001086-27 A Multicenter, Double-blind, Randomized, Parallel Group, Phase 3 Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhale... 2018-07-02 bad-data
Ongoing 2014-001097-34 A Phase 2 Randomised, Double-blind, Placebo-controlled, Single-dose, Dose-ranging Study of the Efficacy and Safety of MEDI4893, a Human Monoclonal Antibody Against Staphylococcus aureus Alpha Toxin in... not-yet-due
Reported results 2014-001102-17 A 26-week International, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase 3bTrial with a Blinded 26-week Long -term Extension Period to Evaluate the Efficacy and Safety ... 2016-10-26 due-trials
Reported results 2014-001391-54 A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid Use in Adults and Adolesc... 2017-09-07 due-trials
Reported results 2014-001457-16 A randomised, double-blind, double-dummy, multi-site, phase III, single dose, 4-way cross-over pharmacodynamic study evaluating the efficacy of Bricanyl Turbuhaler M3 compared to Bricanyl Turbuhaler M... 2015-11-05 due-trials
Ongoing 2014-001589-85 A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Maintenance Olaparib Monotherapy in Patients with gBRCA Mutated Metastatic Pancreatic Cancer whose Disease Has Not Progr... not-yet-due
Ongoing 2014-001858-41 A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) not-yet-due
Listed as ongoing, but also has a completion date 2014-002601-38 A 24-Month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker and Pharmacokinetics Study of AZD3293 in Early Alzheimer’s Disease (The... 2018-10-04 bad-data
Ongoing 2014-002694-11 A phase III, double-blind, randomised study to assess the efficacy and safety of AZD9291 versus a standard of care Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor as first-line treatment in... not-yet-due
Ongoing 2014-003233-26 A Pivotal Multicenter Trial of Moxetumomab Pasudotox in Relapsed/Refractory Hairy Cell Leukemia not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-003242-28 A single blind, randomised, multi-centre, active controlled, trial to evaluate safety, tolerability, pharmacokinetics and efficacy of ceftazidime and avibactam when given in combination with metronida... 2017-06-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-003243-34 Open-label, Multicentre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline in Neonates and Young Infants with Late-Onset Sepsis 2017-12-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-003244-13 A single blind, randomised, multi-centre, active controlled, trial to evaluate safety, tolerability, pharmacokinetics and efficacy of ceftazidime and avibactam compared with cefepime in children from ... 2017-09-15 bad-data
Listed as ongoing, but also has a completion date 2014-003295-23 A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) . 2017-08-02 bad-data
No trial status on register 2014-003400-70 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of MEDI3250 Compared to Placebo in Healthy Japanese Children age 7 years through 18 years bad-data
No trial status on register 2014-003401-15 A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children age 2 years through 6 years bad-data
Ongoing 2014-003438-20 A Phase III, Open Label, Randomised, Controlled, Multi-centre Study to assess the efficacy and safety of Olaparib Monotherapy versus Physician’s Choice Single Agent Chemotherapy in the Treatment of Pl... not-yet-due
Reported results 2014-003502-33 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel group, Phase 3 Trial to Evaluate the Safety and Efficacy of Once Weekly Exenatide Therapy Added to Titrated Basal Insulin Glargine... 2016-08-29 due-trials
Completed, report not yet due 2014-003503-29 A 28-week, Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study with a 24-week Extension Phase Followed by a 52-week Extension Phase to Evaluate the Efficacy and Safety of Simultane... 2017-12-28 not-yet-due
Reported results 2014-003511-11 A Two-part, Open-label, Randomised, Crossover, Multicentre, Phase II Study to Investigate the Presence of Pancreatic Exocrine Insufficiency (PEI) in Patients with Type 2 Diabetes Mellitus, and to Inve... 2015-11-19 due-trials
Reported results 2014-003637-26 A double-blind randomized placebo-controlled, parallel-group 12 week study to investigate the effects of Epanova® compared to placebo and compared to Fenofibrate on liver Fat content in hypertriglyce... 2016-05-26 due-trials
Reported results 2014-003638-26 A double-blind randomized placebo-controlled, parallel-group 12 week study to investigate the effects of Epanova® and dapagliFlozin on liver Fat contEnt in type 2 diabetiC patienTs; 2015-12-11 due-trials
Reported results 2014-003716-36 A Phase 1/2, Randomized, Double-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MEDI0382 in Overweight and Obese Subjects with a Hist... 2017-02-24 due-trials
Ongoing 2014-003717-29 A Phase II, Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic... not-yet-due
Ongoing 2014-003721-18 A 52-week International, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase 3bTrial with a Blinded 104-week Long -term Extension Period to Evaluate the Efficacy and Safety... not-yet-due
Reported results 2014-003725-17 A Phase 2b, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Tralokinumab in Adult Subjects with Moderate-to-Severe Atopic Dermatitis 2016-02-05 due-trials
Other 2014-003863-40 A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Therapy in Patients with Recurrent or Metas... not-yet-due
Listed as ongoing, but also has a completion date 2014-003896-41 A Phase 2a, Randomized, Placebo-controlled, Proof of Mechanism Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Subjects with Primary Sjogren’s Syndrome 2018-08-13 bad-data
No trial status on register 2014-004132-20 A multicentre, double-blind, randomised, parallel-group, Phase III study to assess efficacy and safety of D9421-C 9 mg versus Mesalazine 3 g in patients with active Crohn’s Disease in Japan bad-data
Reported results 2014-004427-40 A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients with Mild to Moderate Persistent Asthma 2015-10-07 due-trials
Completed, report not yet due 2014-004599-49 A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Dapagliflozin as an Add-on to Insulin Therapy in Subjects with Type 1 ... 2018-04-18 not-yet-due
Ongoing 2014-004632-19 A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus not-yet-due
Ongoing 2014-004633-96 A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study Evaluating the Efficacy and Safety of Two Doses of Anifrolumab in Adult Subjects with Active Systemic Lupus Erythematosus not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-004715-37 A randomised, double blind, placebo controlled, parallel study to assess the benefits of aclidinium bromide in the relief of COPD symptoms including cough when administered to patients with COPD 2015-11-17 bad-data
Reported results 2014-004746-99 An Open-Label Long-Term Extension to the Randomized, Double-blind, Placebo-controlled, Multi-center, Cross-over Study of Rosuvastatin in Children and Adolescents (aged 6 to <18 years) with Homozygous ... 2016-11-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2014-004902-13 A 12-Week, Multicenter, Randomized, Parallel-Group Study to Assess the Safety, Tolerability, Pharmacokinetics, Biomarker Effects, Efficacy, and Effect on Microglia Activation, as Measured by Positron ... 2016-09-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2014-005084-32 A randomized, double-blind, placebo-controlled, parallel group, multi-centre Phase IIa study in asthma patients comparing the efficacy and safety of once daily inhaled Interferon beta-1a to placebo, a... 2016-11-18 bad-data
Reported results 2014-005306-37 A randomized, double-blind, multiple dosing (14 days), placebo-controlled, incomplete block crossover, multi-center study to assess efficacy and safety of three dose levels of AZD7594, given once dail... 2016-02-08 due-trials
Reported results 2014-005318-50 A MULTIPLE DOSE, RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL CLINICAL TRIAL TO ASSESS THE EFFECT OF ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE FIXED-DOSE COMBINATION ON LUNG HYPERINFLATION, EXE... 2016-07-25 due-trials
Ongoing, reported early 2014-005377-36 An 8-week, single centre, randomized, parallel-group, double-blind, placebo controlled phase IV study to evaluate Dapagliflozin 10 mg once daily effects on insulin resistance in subjects with type 2 d... not-yet-due
Reported results 2014-005450-19 A Phase 1, Open-label Study to Evaluate the Pharmacokinetics of MEDI9929 in Adolescents with Mild to Moderate Asthma 2016-05-17 due-trials
Reported results 2015-000159-26 A Phase 2a, Multi-centre, Single-arm Trial of the Combination of AZD2014 and Weekly Paclitaxel in Patients with Relapsed or Refractory Squamous Non-Small Cell Lung Cancer After at Least One Line of Pr... 2016-12-29 due-trials
Ongoing 2015-000408-24 A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Assess the Safety and Efficacy of Exenatide Once Weekly in Adolescents with Type 2 Diabetes not-yet-due
Reported results 2015-000595-10 A Phase 2a, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects with Moderate-to-Severe Atopic Dermatitis 2016-07-14 due-trials
Listed as ongoing, but also has a completion date 2015-000609-38 A Phase 2B Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MEDI2070 in Subjects with Moderate to Severe Crohn’s Disease Who Have Failed or Are Intolerant to A... 2018-01-29 bad-data
Ongoing 2015-000662-65 A Phase III, double-blind, randomized, placebo-controlled multi-centre, study to assess the efficacy and safety of AZD9291 versus Placebo, in patients with Epidermal Growth Factor Receptor Mutation Po... not-yet-due
Ongoing 2015-000734-30 An Open Label, Single Arm, Multicentre Study to Assess the Clinical Effectiveness and Safety of Lynparza (Olaparib) Capsules Maintenance Monotherapy in Platinum Sensitive Relapsed BRCA Mutated Ovarian... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2015-000804-24 A Multicenter, Double-Blind, Placebo-Controlled, Parallel Group, Randomized, Phase III study to Evaluate the Glycemic Efficacy and Renal Safety of dapagliflozin in patients with Type 2 Diabetes Mellit... 2017-11-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2015-000857-19 A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, 12-Week, Phase 2 Study to Evaluate the Effect of Tralokinumab on Airway Inflammation in Adults with Asthma Inadequately Con... 2017-06-21 bad-data
Ongoing 2015-000886-30 A Multicentre Phase II Study of AZD1775 plus Chemotherapy in Patients with Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. not-yet-due
Ongoing 2015-001279-39 A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination with Tremelimumab Therapy or MEDI4736 Monotherapy Versus Standard of Care Platinum-Based Chemotherapy in First... not-yet-due
Ongoing 2015-001407-31 Open Label, Multinational, Multicenter, Real World Treatment Study of Single Agent AZD9291 for Patients with Advanced/Metastatic Epidermal Growth Factor Receptor (EGFR) T790M Mutation-Positive Non-Sma... not-yet-due
Ongoing 2015-001442-29 A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2 Study Evaluating the Efficacy and Safety of Anifrolumab in Adult Subjects with Active Proliferative Lupus Nephritis not-yet-due
Ongoing 2015-001633-24 A Phase III, Randomized, Open-label, Controlled, Multi-Center, Global Study of First-Line MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Pat... not-yet-due
Ongoing 2015-001663-39 A Study of Safety, Tolerability, and Clinical Activity of MEDI4736 and Tremelimumab Administered as Monotherapy and in Combination to Subjects with Unresectable Hepatocellular Carcinoma not-yet-due
Completed, report not yet due 2015-001702-33 A 24-week International, Multicenter, Randomized, Open-Label, Active-Controlled, Parallel Group, Phase 3b Trial with a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administe... 2017-11-10 not-yet-due
Ongoing 2015-001706-34 A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa. not-yet-due
Reported results 2015-002001-11 A Phase II Open-Label, Multi-Center Study of MEDI4736 Evaluated as Single Agent or in Combination with Tremelimumab in Patients with Metastatic Pancreatic Ductal Adenocarcinoma 2017-06-26 due-trials
Ongoing 2015-002197-21 A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination with Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patie... not-yet-due
Reported results 2015-002376-24 A 52-Week, Multi-Centre, Randomised, Parallel-Group, Double-Blind, Active Controlled, Phase IV Study to Evaluate the Safety and Efficacy of Dapagliflozin or Dapagliflozin plus Saxagliptin compared wit... 2017-03-13 due-trials
Ongoing 2015-002525-19 A Phase 1b/2, Open-Label, Multicentre Study Assessing the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumour Activity of MEDI4736 in Combination With AZD9150 or AZD5069 in Patients Wi... not-yet-due
Completed, but no date 2015-002676-24 An exploratory Phase II/III, randomized, double-blind, placebo controlled, parallel design study to evaluate the efficacy, safety and pharmacodynamics of dapagliflozin and dapagliflozin in combination... bad-data
Completed, report not yet due 2015-002726-39 A Phase IIa prospective, open-label, multicenter study to determine the pharmacokinetics (PK) and safety and tolerability of aztreonam-avibactam (ATM-AVI) for the treatment of complicated Intra-Abdomi... 2017-10-26 not-yet-due
Reported results 2015-002758-11 A Phase 2b Randomized, Double-blind Study to Evaluate the Efficacy of MEDI7510 for the Prevention of Acute Respiratory Syncytial Virus-associated Respiratory Illness in Older Adults 2016-11-07 due-trials
Ongoing 2015-002934-32 A Phase II, Multi-Center, Open-Label Study of Tremelimumab Monotherapy in Patients with Advanced Solid Tumors not-yet-due
Ongoing 2015-003320-30 A Phase I/II Multicenter Study of the Combination of AZD2014 and Palbociclib on a background of Hormonal Therapy in Patients with Locally Advanced/Metastatic Estrogen Receptor Positive Breast Cancer C... not-yet-due
Ongoing 2015-003589-10 A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squa... not-yet-due
Ongoing 2015-003639-37 A Phase Ib and II Open-Label, Multi-Center Study of MEDI4736 Evaluated in Different Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma not-yet-due
Ongoing 2015-003715-38 A Phase 1b Open-label Study to Evaluate the Safety and Tolerability of MEDI4736 in Combination with Tremelimumab in Subjects with Advanced Non-small Cell Lung Cancer not-yet-due
Ongoing 2015-004005-16 A Phase I/II Study of MEDI4736 (Anti-PD-L1 Antibody) in Combination with Olaparib (PARP inhibitor) in Patients with Advanced Solid Tumors not-yet-due
Listed as ongoing, but also has a completion date 2015-004276-29 A Phase 2b, Randomized, Double-blind, Single-dose, Active-controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults who are Hospitalized with Influenza Caused by Type A ... 2017-03-16 bad-data
Ongoing 2015-004825-14 A 24-Week, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study to Investigate the Effects of Saxagliptin and Sitagliptin in Patients with Type 2 Diabetes Mellitus and Hea... not-yet-due
Ongoing 2015-005041-31 A 24 Week, Multicenter, Randomized, Double-Blind, Parallel Group, Phase 3 Trial with a 28 Week Long Term Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 10 mg in T2DM Patie... not-yet-due
Ongoing 2015-005042-66 A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 ... not-yet-due
Ongoing 2015-005396-25 A Multicenter, Open-label, Safety Extension Study with Benralizumab (MEDI-563) for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting ?2 Agonist (MELTEMI) not-yet-due
Reported results 2015-005406-11 A Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin 5mg Co-administered with Dapagliflozin 5mg compared to S... 2017-07-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2015-005444-33 A 24 week treatment, multicenter, randomized, double blinded, double dummy, parallel-group, clinical trial evaluating the efficacy and safety of aclidinium bromide 400 mcg/formoterol fumarate 12 mcg f... 2017-06-08 bad-data
Completed, report not yet due 2016-000154-34 A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005, PT008, and Open-label Symbicort® Turbuhaler®,as an Active Control, on Lung ... 2017-12-01 not-yet-due
Ongoing 2016-000300-28 A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Canc... not-yet-due
Ongoing 2016-000323-43 A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination with Durvalumab versus Nivolumab Monotherapy in Subjects with Select Advanced Malignanc... not-yet-due
Ongoing 2016-000625-39 A Multicentre, Randomised, Double-blind, Placebo-Controlled Phase 3 Extension Study to Characterise the Long-term Safety and Tolerability of Anifrolumab in Adult Subjects with Active Systemic Lupus Er... not-yet-due
Ongoing 2016-000662-38 A Phase 1 Study of Durvalumab and IPH2201 in Adult Subjects with Select Advanced Solid Tumors not-yet-due
Listed as ongoing, but also has a completion date 2016-000977-19 A Phase 2 Placebo-Controlled, Randomized, Double Blind, Adaptive Dose Trial of the Safety and Efficacy of Inhaled AZD1419 in Adults With Eosinophilic, Moderate to Severe Asthma 2018-09-25 bad-data
Ongoing 2016-001202-42 A Phase II, Open-Label, Multi-Arm Study to Determine the Preliminary not-yet-due
Ongoing 2016-001203-23 A Phase III, Randomized, Multicenter, Open-Label, Comparative Study to Determine the Efficacy of Durvalumab or Durvalumab and Tremelimumab in Combination With Platinum-Based Chemotherapy for the First... not-yet-due
Other 2016-001677-33 A Phase 2b Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in ... not-yet-due
No trial status on register 2016-001717-24 Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vacc... bad-data
Completed, report not yet due 2016-002094-36 A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function with Benralizumab in Severe, Unco... 2018-08-01 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2016-002863-32 A phase IIa, randomised, multi-centre, double blind, placebo-controlled 3 periods, crossover study to investigate the efficacy, pharmacokinetics, safety and tolerability of inhaled AZD8871 administer... 2017-08-18 bad-data
Ongoing 2016-002961-79 DAPASALT: An Open Label, Phase IV, Mechanistic, Three-Arm Study to Evaluate the Natriuretic Effect of 2-Week Dapagliflozin treatment in Type 2 Diabetes Mellitus Patients with Either Preserved or Impai... not-yet-due
Ongoing 2016-003246-93 A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study Characterizing the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab following subcutaneous administration in Adu... not-yet-due
Ongoing 2016-003346-90 A Phase IIIb, Randomised, Double-blind, Placebo-controlled, Multicentre Study of Olaparib Maintenance Retreatment in Patients with Epithelial Ovarian Cancer Previously Treated With a PARPi and Respon... not-yet-due
No trial status on register 2016-003775-22 An Open-label, parallel-group, multi-centre, phase I / III study to assess the safety, pharmacokinetics, pharmacodynamics and efficacy of repeated once-daily oral administration of 961H 10 mg and D961... bad-data
Ongoing 2016-003896-24 A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and not-yet-due
Ongoing 2016-003897-41 Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening not-yet-due
Ongoing 2016-003991-27 MAAST: A Double-blind, Randomized, Phase IV, Mechanistic, Placebo-controlled, Cross-over, Single-center Study to Evaluate the Effects of 5 Weeks Dapagliflozin Treatment on Insulin Sensitivity in Skele... not-yet-due
Ongoing 2016-004108-73 A Phase III, Open Label, Randomised, Controlled, Multi-Centre Study To Assess the Efficacy and Safety of Savolitinib versus Sunitinib in Patients with MET-Driven, Unresectable and Locally Advanced, Or... not-yet-due
Other 2016-004140-10 A randomised, double-blind, placebo- and active-controlled, parallel-arm, multicentre study to assess efficacy, pharmacokinetics, safety and tolerability of multiple dose levels of abediterol administ... not-yet-due
Ongoing 2016-004232-37 A Randomised, Double-Blind, Placebo-Controlled, International, Multicentre, Phase III Study to Investigate the Efficacy and Safety of Ticagrelor and ASA Compared with ASA in the Prevention of Stroke a... not-yet-due
Completed, report not yet due 2016-004655-75 A Randomised, Double-Blind, Double-Dummy, Multicentre, Parallel Group Study to Assess the Efficacy and Safety of Glycopyrronium/Formoterol Fumarate fixed-dose combination relative to Umeclidinium/Vila... 2018-05-04 not-yet-due
Ongoing 2016-005068-33 An Open-Label, Multi-Centre, Safety Study of Fixed-Dose Durvalumab + Tremelimumab Combination Therapy or Durvalumab Monotherapy in Advanced Solid Malignancies not-yet-due
Ongoing 2016-005126-11 A Randomized, Open-label, Multi-center Phase III Study of Durvalumab and Tremelimumab as First-line Treatment in Patients with Unresectable Hepatocellular Carcinoma not-yet-due
Ongoing 2017-000626-35 A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subje... not-yet-due
No trial status on register 2017-000702-38 A Multicentre, Randomised, Double-blind, Parallel Group, Placebocontrolled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) Added to Medium to High-dose Inhaled Corticosteroid Plus Long-a... bad-data
Ongoing 2017-000838-64 A Phase 2a, Randomised, Double-blind, Parallel Study to Assess the Efficacy, Safety and Tolerability of AZD9567 compared to Prednisolone 20 mg in patients with active Rheumatoid Arthritis (RA) not-yet-due
No trial status on register 2017-000848-17 A Phase 2, Open-Label, Single Arm Trial to Evaluate the Shedding and Safety of CAIV-T Administered to Children 6 to less than 60 Months of Age bad-data
No trial status on register 2017-000849-50 A Phase I Randomized, Double-Blind Trial of the Safety and Immunogenicity of FluMist® A Live, Intranasal Influenza Virus Vaccine vs. Placebo in Immunocompromised Children Ages 5 Through 17 Years of Ag... bad-data
Ongoing 2017-000920-81 A Phase III, Randomized, Multi-Center, Open-Label, Comparative Global Study to Determine the Efficacy of Durvalumab or Durvalumab and Tremelimumab in Combination With Platinum-Based Chemotherapy for F... not-yet-due
Ongoing 2017-001040-35 A Multicenter, Randomized, Double-blind, Parallel Group, Placebo controlled, Phase 3b Study to Evaluate the Safety and Efficacy of Benralizumab 30 mg sc in Patients with Severe Asthma Uncontrolled on ... not-yet-due
Ongoing 2017-001054-34 LUCY - Lynparza Breast Cancer Real World Utility, Clinical Effectiveness and Safety Study not-yet-due
Ongoing 2017-001582-25 A 12-week, randomized, single-blind, placebo-controlled, multi-centre, parallel group, phase IIa study to evaluate efficacy, safety and tolerability of oral AZD5718 after 4- and 12-weeks of treatment ... not-yet-due
Completed, report not yet due 2017-001902-14 A Phase 1/2 Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI4276 in Subjects with Select HER2... 2018-05-23 not-yet-due
Completed, report not yet due 2017-002025-38 A Phase 2, Randomised, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Different Doses of MEDI0382 in Overweight and Obese Subjects wit... 2018-01-23 not-yet-due
Ongoing 2017-002208-28 An Open-Label, Multi-Drug, Biomarker-Directed, Multi-Centre Phase II Umbrella Study in Patients with Non-Small Cell Lung Cancer, who Progressed on an anti-PD-1/PD-L1 Containing Therapy (HUDSON). not-yet-due
Other 2017-002359-27 A Multicentre, Open-label, Single-arm, Molecular Profiling Study of Patients with EGFR Mutation-positive Locally Advanced or Metastatic NSCLC Treated with Osimertinib not-yet-due
Ongoing 2017-002361-22 A Phase II, Open Label, Randomised, Multi-centre Study to Assess the Safety and Efficacy of Agents Targeting DNA Damage Repair in Combination with Olaparib versus Olaparib Monotherapy in the Treatment... not-yet-due
Ongoing 2017-002421-38 A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with S... not-yet-due
Ongoing 2017-002483-40 A Phase 2b Randomised, Double Blind, Placebo Controlled, Parallel Arm, Multi Centre Study to Assess Efficacy and Safety of Multiple Dose Levels of AZD7594 DPI Given Once Daily for twelve weeks, compar... not-yet-due
Ongoing 2017-002690-19 A randomized, double-blind, placebo-controlled, multi-centre, sequential design, phase IIa study to evaluate safety and tolerability of epicardial injections of AZD8601 during coronary bypass graftin... not-yet-due
Ongoing 2017-002767-17 A Phase IIIb, Single-arm, Open-label Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed non-Germline BRCA Mutated Ovarian Cancer Patients who are in Complete or Parti... not-yet-due
Ongoing 2017-002817-78 An Exploratory Phase 2a Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy and Safety of MEDI0382 versus Placebo in Overweight/Obese Subjects with Type 2 Diabetes Mellitus Tre... not-yet-due
Ongoing 2017-002979-26 A Phase III Randomized, Open-Label, Multi-Center, Global Study of Durvalumab and Bacillus Calmette-Guerin (BCG) Administered as Combination Therapy Versus BCG Alone in High-Risk, BCG Naïve Non Muscle ... not-yet-due
Other 2017-003078-15 A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma ... not-yet-due
Ongoing 2017-003079-69 A Multicentre, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults with Oral Corticosteroid Dep... not-yet-due
Ongoing 2017-003641-14 A Multi-centre, Phase I, Open-label, Single-dose Study to Investigate Pharmacokinetics (PK) of Ticagrelor in Infants and Toddlers, Aged 0 to less than 24 Months, with Sickle Cell Disease not-yet-due
Ongoing 2017-003675-61 A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis not-yet-due
Ongoing 2017-003820-58 A double-blind, randomized, parallel group, phase IV study to investigate the effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency and myocardial contractile work in type 2 diab... not-yet-due
Ongoing 2017-003955-50 A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ENERGIZE) not-yet-due
Ongoing 2017-004397-34 A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Given Concurrently with Platinum-based Chemoradiation Therapy in Patients with Locally Advanc... not-yet-due
Ongoing 2017-004521-32 A Randomized, Placebo-controlled Phase 2b Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction not-yet-due
Ongoing 2017-004556-27 A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Cisplatin-Ineli... not-yet-due
Ongoing 2017-005081-22 An Exploratory Phase 2, Randomised, Double-blind, Placebo-controlled, and Open-label Active Comparator Study to Evaluate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese S... not-yet-due
Ongoing 2018-000170-30 A Multicenter, Open-label, Phase 3b Efficacy and Safety Study of Benralizumab 30 mg Administered Subcutaneously to Reduce Oral Corticosteroid Use in Adult Patients with Severe Eosinophilic Asthma on H... not-yet-due
Ongoing 2018-000175-33 A Phase II, Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicentre, Three Month Duration Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy with Sodium Zirconium Cyc... not-yet-due
Ongoing 2018-000802-46 An International, Double-blind, Randomised, Placebo-Controlled Phase IIIb Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure w... not-yet-due
Ongoing 2018-001061-16 A Phase III, randomized, double-blind, placebo-controlled, multicenter, international study of Osimertinib as maintenance therapy in patients with locally advanced, unresectable EGFR mutation-positive... not-yet-due
Ongoing 2018-001375-21 A Phase III Randomized, Open-Label, Multi-Center Study of Durvalumab (MEDI4736) Versus Standard of Care (SoC) Platinum-Based Chemotherapy as First Line Treatment in Patients with PD-L1-High Expression... not-yet-due
Ongoing 2018-001883-48 Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and... not-yet-due
Ongoing 2018-002069-21 A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Cort... not-yet-due
No trial status on register 2018-003701-26 A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age bad-data